AAPM (1986). American Association of Physicists in Medicine. Protocol for Heavy Charged-Particle Therapy Beam Dosimetry. AAPM Report 16 (American Association of Physicists in Medicine, New York).
2.
AbleitingerA., VatnitskyS., HerrmannR., BasslerN., PalmansH., SharpeP., EckerS., ChaudhriN., JäkelO., and GeorgD. (2013). ‘Dosimetry auditing procedure with alanine dosimeters for light ion beam therapy,’ Radiother. Oncol.108, 99–106.
3.
AcharyaS., Fischer-ValuckB.W., KashaniR., ParikhP., YangD., ZhaoT., GreenO., WootenO., LiH.H., HuY., RodriguezV., OlsenL., RobinsonC., MichalskiJ., MuticS., and OlsenJ. (2016). ‘Online magnetic resonance image guided adaptive radiation therapy: first clinical applications,’ Int. J. Radiat. Oncol. Biol. Phys.94, 394–403.
4.
AlbertiniF., BolsiA., LomaxA.J., RutzH.P., TimmermanB., and GoiteinG. (2008). ‘Sensitivity of intensity modulated proton therapy plans to changes in patient weight,’ Radiother. Oncol.86, 187–194.
5.
AlbertiniF., HugE.B., and LomaxA.J. (2011). ‘Is it necessary to plan with safety margins for actively scanned proton therapy?,’ Phys. Med. Biol.56, 4399.
AlrowailiZ.A., LerchM.L.F., PetaseccaM., CarolanM.G., MetcalfeP.E., and RosenfeldA.B. (2016). ‘Beam perturbation characteristics of a 2D transmission silicon diode array, magic plate,’ J. Appl. Clin. Med. Phys.17, 85–98.
8.
AmaldiU., and KraftG. (2009). ‘Hadrontherapy: Cancer treatment with proton and carbon beams,’ pp. 165–171 in Radiotherapy and Brachytherapy, LemoigneY., and CanerA., Eds. (Springer, New York).
9.
AminM.B., GreeneF.L., EdgeS.B., ComptonC.C., GershenwaldJ.E., BrooklandR.K., MeyerL., GressD.M., ByrdD.R., and WinchesterD.P. (2017). ‘The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging,’ CA Cancer J. Clin.67, 93–99.
10.
AmmazzalorsoF., JelenU., Engenhart-CabillicR., and SchlegelW. (2014). ‘Dosimetric robustness against setup errors in charged particle radiotherapy of skull base tumors,’ Radiat. Oncol.9, 279.
11.
AnderleK., StroomJ., PimentelN., GrecoC., DuranteM., and GraeffC. (2016). ‘In silico comparison of photons versus carbon ions in single fraction therapy of lung cancer,’ Phys. Med.32, 1118–1123.
12.
AndreoP. (2009). ‘On the clinical spatial resolution achievable with protons and heavier charged particle radiotherapy beams,’ Phys. Med. Biol.54, N205–N215.
13.
AndreoP., WulffJ., BurnsD.T., PalmansH. (2013). ‘Consistency in reference radiotherapy dosimetry: resolution of an apparent conundrum when 60Co is the reference quality for charged-particle and photon beams,’ Phys. Med. Biol.58, 6593–6621.
ArjomandyB., SahooN., ZhuX.R., ZulloJ.R., WuR.Y., ZhuM.P., DingX.N., MartinC., CiangaruG., and GillinM.T. (2009). ‘An overview of the comprehensive proton therapy machine quality assurance procedures implemented at The University of Texas M. D. Anderson Cancer Center Proton Therapy Center-Houston,’ Med. Phys.36, 2269–2282.
BadanoL., CrescentiM., HolyP., MaierA.T., KnausP., BryantP.J., BenediktM., PulliaM., and RossiS. (1999). Proton-Ion Medical Machine Study (PIMMS), Part 1, CERN PS-99-010-D1(CERN, Geneva).
18.
BaekH.J., KimT.H., ShinD.H., KwakJ.W., ChooD.W., LeeS.B., FurusawaY., AndoK., KimS.S., and ChoK.H. (2008). ‘Radiobiological characterization of proton beam at the National Cancer Center in Korea,’ J. Radiat. Res. Oncol. Biol. Phys.49, 509–515.
19.
BalterJ.M., LamK.L., McGinnC.J., LawrenceT.S., and Ten HakenR.K. (1998). ‘Improvement of CT-based treatment-planning models of abdominal targets using static exhale imaging,’ Int. J. Radiat. Oncol. Biol. Phys.41, 939–943.
20.
BalterJ.M., WrightJ.N., NewellL.J., FriemelB., DimmerS., ChengY., WongJ., VertatschitschE., and MateT.P. (2005). ‘Accuracy of a wireless localization system for radiotherapy,’ Int. J. Radiat. Oncol. Biol. Phys.61, 933–937.
21.
BasslerN., JäkelO., SøndergaardC.S., and PetersenJ.B. (2010). ‘Dose-and LET-painting with particle therapy,’ Acta Oncol.49, 1170–1176.
22.
BasslerN., ToftegaardJ., LuhrA., SorensenB.S., ScifoniE., KramerM., JäkelO., MortensenL.S., OvergaardJ., and PetersenJ.B. (2014). ‘LET-painting increases tumour control probability in hypoxic tumours,’ Acta Oncol.53, 25–32.
23.
BattistoniG., BauerJ., BoehlenT.T., CeruttiF., ChinM.P., Dos Santos AugustoR., FerrariA., OrtegaP.G., KozlowskaW., MagroG., MairaniA., ParodiK., SalaP.R., SchoofsP., TessonnierT., and VlachoudisV. (2016). ‘The FLUKA Code: an accurate simulation tool for particle therapy,’ Front. Oncol.6, 116.
24.
BauerJ., UnholtzD., SommererF., KurzC., HabererT., HerfarthK., WelzelT., CombsS.E., DebusJ., and ParodiK. (2013). ‘Implementation and initial clinical experience of offline PET/CT-based verification of scanned carbon ion treatment,’ Radiother. Oncol.107, 218–226.
25.
BaumC., AlberM., BirknerM., and NusslinF. (2006). ‘Robust treatment planning for intensity modulated radiotherapy of prostate cancer based on coverage probabilities,’ Radiother. Oncol.78, 27–35.
26.
BäumerC., AckermannB., HillbrandM., KaiserF.J., KoskaB., LatzelH., LuhrA., MenkelS., and TimmermannB. (2016). ‘Dosimetry intercomparison of four proton therapy institutions in Germany employing spot scanning,’ Z. Med. Phys.27, 80–85.
27.
BeadleB.M., JhingranA., SalehpourM., SamM., IyerR.B., and EifelP.J. (2009). ‘Cervix regression and motion during the course of external beam chemoradiation for cervical cancer,’ Int. J. Radiat. Oncol. Biol. Phys.73, 235–241.
28.
BechtoldA., SchemppA., RatzingerU., and SchlittB. (2000). ‘Development of an RFQ-injector for a therapy-synchrotron,’ pp. 2500 to 2502 in EPAC 2000: Seventh European Accelerator Conference, Vienna 26 to 30 June 2000 (CERN, Geneva).
29.
BenedictS.H., BovaF.J., ClarkB., GoetschS.J., HinsonW.H., LeavittD.D., SchlesingerD.J., and YeniceK.M. (2008). ‘Anniversary paper: The role of medical physicists in developing stereotactic radiosurgery,’ Med. Phys.35, 4262–4277.
30.
Bentefour elH., BothS., TangS., and LuH.M. (2015). ‘Using CBCT for pretreatment range check in proton therapy: a phantom study for prostate treatment by anterior-posterior beam,’ J. Appl. Clin. Med. Phys.16, 5212.
31.
BentzenS.M., DörrW., GahbauerR., HowellR.W., JoinerM.C., JonesB., JonesD.T., van der KogelA.J., WambersieA., and WhitmoreG. (2012). ‘Bioeffect modeling and equieffective dose concepts in radiation oncology–terminology, quantities and units,’ Radiother. Oncol.105, 266–268.
32.
BertC., and DuranteM. (2011). ‘Motion in radiotherapy: particle therapy,’ Phys. Med. Biol.56, R113–R144.
33.
BertC., and RietzelE. (2007). ‘4D treatment planning for scanned ion beams,’ Radiat. Oncol.2, 24.
34.
BertC., SaitoN., SchmidtA., ChaudhriN., SchardtD., and RietzelE. (2007). ‘Target motion tracking with a scanned particle beam,’ Med. Phys.34, 4768–4771.
35.
BertC., GrozingerS.O., and RietzelE. (2008). ‘Quantification of interplay effects of scanned particle beams and moving targets,’ Phys. Med. Biol.53, 2253–2265.
36.
BertC., GemmelA., SaitoN., and RietzelE. (2009). ‘Gated irradiation with scanned particle beams,’ Int. J. Radiat. Oncol. Biol. Phys.73, 1270–1275.
37.
BertC., GemmelA., SaitoN., ChaudhriN., SchardtD., DuranteM., KraftG., and RietzelE. (2010). ‘Dosimetric precision of an ion beam tracking system,’ Radiat. Oncol.5, 61.
38.
BertC., GraeffC., RiboldiM., NillS., BaroniG., and KnopfA.C. (2014). ‘Advances in 4D treatment planning for scanned particle beam therapy - report of dedicated workshops,’ Technol. Cancer Res. Treat.13, 485–495.
39.
BerteroL., MassaF., MetovicJ., ZanettiR., CastellanoI., RicardiU., PapottiM., and CassoniP. (2017). ‘Eighth Edition of the UICC classification of malignant tumours: an overview of the changes in the pathological TNM classification criteria – what has changed and why?,’ Virchows Arch.472, 519–531.
40.
BichselH., and HiraokaT. (1992). ‘Energy-loss of 70 MeV protons in elements,’ Nucl. Instrum. Methods Phys. Res. B66, 345–351.
41.
BIPM (2006). Bureau International des Poids etMesures. The International System of Units 91 (SI). (Bureau International des Poids etMesures, Sèvres Cedex, France).
42.
BlakelyE.A., TobiasC.A., YangT.C., SmithK.C., and LymanJ.T. (1979). ‘Inactivation of human kidney cells by high-energy monoenergetic heavy-ion beams,’ Radiat. Res.80, 122–160.
BlakelyE., TobiasC., LudewigtB., and ChuW. (1987). ‘Some physical and biological properties of light ions,’ pp. 19 to 41 in Proc. 5th PTOG Meeting and International Workshop on Biomeidal Accelerators, LBL-22962 (National Technical Information Service, Springfield, Virginia).
45.
BöhlenT.T., BronsS., DosanjhM., FerrariA., FossatiP., HabererT., PateraV., and MairaniA. (2012). ‘Investigating the robustness of ion beam therapy treatment plans to uncertainties in biological treatment parameters,’ Phys. Med. Biol.57, 7983–8004.
46.
BohmD., and FoldyL.L. (1947). ‘Theory of the synchro-cyclotron,’ Phys. Rev.72, 649–661.
47.
BolsiA., LomaxA.J., PedroniE., GoiteinG., and HugE. (2008). ‘Experiences at the Paul Scherrer Institute with a remote patient positioning procedure for high-throughput proton radiation therapy,’ Int. J. Radiat. Oncol. Biol. Phys.71, 1581–1590.
48.
BortfeldT., JokivarsiK., GoiteinM., KungJ., and JiangS.B. (2002). ‘Effects of intra-fraction motion on IMRT dose delivery: statistical analysis and simulation,’ Phys. Med. Biol.47, 2203–2220.
49.
BortfeldT., JiangS.B., and RietzelE. (2004). ‘Effects of motion on the total dose distribution,’ Semin. Radiat. Oncol.14, 41–51.
50.
BouchetL.G., MeeksS.L., GoodchildG., BovaF.J., BuattiJ.M., and FriedmanW.A. (2001). ‘Calibration of three-dimensional ultrasound images for image-guided radiation therapy,’ Phys. Med. Biol.46, 559–577.
51.
BraggW.H., and KleemanR. (1904). ‘LXXIV. On the ionization curves of radium,’ Lond. Edinb. Dubl. Phil. Mag. J. Sci.8, 726–738.
52.
BredeH.J., GreifK.D., HeckerO., HeegP., HeeseJ., JonesD.T., KlugeH., and SchardtD. (2006). ‘Absorbed dose to water determination with ionization chamber dosimetry and calorimetry in restricted neutron, photon, proton and heavy-ion radiation fields,’ Phys. Med. Biol.51, 3667–3682.
53.
BrevetR., RichterD., GraeffC., DuranteM., and BertC. (2015). ‘Treatment parameters optimization to compensate for interfractional anatomy variability and intrafractional tumor motion,’ Front. Oncol.5, 291.
54.
BrierleyJ.D., GospodarowiczM.K., and WittekindC. (2017). TNM Classification of Malignant Tumours, 8th ed. (John Wiley & Sons, Hoboken, New Jersey).
55.
BrockK.K., DawsonL.A., SharpeM.B., MoseleyD.J., and JaffrayD.A. (2006). ‘Feasibility of a novel deformable image registration technique to facilitate classification, targeting, and monitoring of tumor and normal tissue,’ Int. J. Radiat. Oncol. Biol. Phys.64, 1245–1254.
56.
BrusascoC., VossB., SchardtD., KramerM., and KraftG. (2000). ‘A dosimetry system for fast measurement of 3D depth-dose profiles in charged-particle tumor therapy with scanning techniques,’ Nucl. Instrum. Methods Phys. Res. B168, 578–592.
57.
BryantP.J., WeisserL., BadanoL., BorriG., CrescentiM., HolyP., ReimoserS., MaierA.T., KnausP., and PavlovicM. (2000). Proton-Ion Medical Machine Study (PIMMS), Part 2, CERN/PS 2000-007 (CERN, Geneva).
58.
BurigoL., GreilichS. (2019). ‘Imapct of new ICRU 90 key data on stopping-power ratios and beam quality correction factors for carbon ion beams,’ Phys. Med. Biol.64: 195005.
59.
CabalG.A., and JäkelO. (2013). ‘Dynamic target definition: a novel approach for PTV definition in ion beam therapy,’ Radiother. Oncol.107, 227–233.
60.
CantoneM.C., CioccaM., DionisiF., FossatiP., LorentiniS., KrengliM., MolinelliS., OrecchiaR., SchwarzM., VeroneseI., and VitoloV. (2013). ‘Application of failure mode and effects analysis to treatment planning in scanned proton beam radiotherapy,’ Radiat. Oncol.8, 127.
61.
CaoW., LimG.J., LeeA., LiY., LiuW., Ronald ZhuX., and ZhangX. (2012). ‘Uncertainty incorporated beam angle optimization for IMPT treatment planning,’ Med. Phys.39, 5248–5256.
62.
Capote NoyR., and VatnitskiyS. (2007). Summary Report of Consultants’ Meeting on Nuclear Data of Charged-Particle Interactions for Medical Therapy Applications, INDC(NDS)-0504 (International Atomic Energy Agency, Geneva).
63.
CarrollP.R., ParsonsJ.K., AndrioleG., BahnsonR.R., CastleE.P., CatalonaW.J., DahlD.M., DavisJ.W., EpsteinJ.I., EtzioniR.B., FarringtonT., HemstreetG.P.III, KawachiM.H., KimS., LangeP.H., LoughlinK.R., LowranceW., MaroniP., MohlerJ., MorganT.M., MosesK.A., NadlerR.B., PochM., ScalesC., ShaneyfeltT.M., SmaldoneM.C., SonnG., SprenkleP., VickersA.J., WakeR., SheadD.A., and Freedman-CassD.A. (2016). ‘NCCN guidelines insights: prostate cancer early detection, Version 2.2016,’ J. Natl. Compr. Canc. Netw.14, 509–519.
64.
CastriconiR., CioccaM., MirandolaA., SiniC., BroggiS., SchwarzM., FracchiollaF., MartisikovaM., AricoG., MettivierG., and RussoP. (2017). ‘Dose-response of EBT3 radiochromic films to proton and carbon ion clinical beams,’ Phys. Med. Biol.62, 377–393.
65.
CastroJ.R. (1993). ‘Heavy ion therapy: The BEVALAC epoch,’ pp. 208 to 216 in Hadrontherapy in oncology: Proc. First International Symp. Hadrontherapy, Amaldi, U. and Larsson, B., Eds. (Elsevier Science, Como, Italy).
66.
CastroJ.R. (1995). ‘Future research strategy for heavy ion radiotherapy,’ pp. 643–648 in Progress in Radio-Oncology, KogelnikH.D., Ed. (Raven Press, New York).
67.
CastroJ.R. (1997). ‘Clinical programs: a review of past and existing hadron protocols,’ pages 79–94 in Advances in Hadron Therapy, Amaldi, U, Larrson, B, Lemoigne, Y (Eds.) (Elsevier Science, Amsterdam).
68.
CastroJ.R., ChenG.T., PitluckS., CartignyA., PhillipsT.L., SaundersW.M., CollierM.J., WoodruffK.H., FriedmanM., and Austin-SeymourM. (1983). ‘Helium charged-particle radiotherapy of locally advanced carcinoma of the esophagus, stomach, and biliary tract,’ Am. J. Clin. Oncol.6, 629–737.
69.
CastroJ.R., LinstadtD.E., BaharyJ.P., PettiP.L., DaftariI., CollierJ.M., GutinP.H., GaugerG., and PhillipsT.L. (1994). ‘Experience in charged particle irradiation of tumors of the skull base: 1977–1992,’ Int. J. Radiat. Oncol. Biol. Phys.29, 647–655.
70.
ChandraA., DongL., HuangE., KubanD.A., O'NeillL., RosenI., and PollackA. (2003). ‘Experience of ultrasound-based daily prostate localization,’ Int. J. Radiat. Oncol. Biol. Phys.56, 436–447.
71.
ChauvelP., and WambersieA. (1998). Proceedings of the EULIMA Workshop on the Potential Value of Light Ion Beam Therapy, EUR 12165 EN (Centre Antoine-Lacassagne, Nice, France).
72.
ChenG.T., SinghR.P., CastroJ.R., LymanJ.T., and QuiveyJ.M. (1979). ‘Treatment planning for heavy ion radiotherapy,’ Int. J. Radiat. Oncol. Biol. Phys.5, 1809–1819.
73.
ChenG.T., KungJ.H., and RietzelE. (2007). ‘Four-dimensional imaging and treatment planning of moving targets,’ Front. Radiat. Ther. Oncol.40, 59–71.
74.
ChenG.T., SharpG.C., and MoriS. (2009). ‘A review of image-guided radiotherapy,’ Radiol. Phys. Technol.2, 1–12.
75.
ChenW., UnkelbachJ., TrofimovA., MaddenT., KooyH., BortfeldT., and CraftD. (2012). ‘Including robustness in multi-criteria optimization for intensity-modulated proton therapy,’ Phys. Med. Biol.57, 591–608.
76.
ChenW., GemmelA., and RietzelE. (2013a). ‘Feature-based plan adaptation for fast treatment planning in scanned ion beam therapy,’ Phys. Med. Biol.58, 1013–1025.
77.
ChenW.J., GemmelA., and RietzelE. (2013b). ‘A patient-specific planning target volume used in ‘plan of the day’ adaptation for interfractional motion mitigation,’ J. Radiat. Res.54, 82–90.
78.
ChuW., LudewigtB., and RennerT. (1993). ‘Instrumentation for treatment of cancer using proton and light‐ion beams,’ Rev. Sci. Instrum.64, 2055–2122.
79.
CombsS.E., JäkelO., HabererT., and DebusJ. (2010). ‘Particle therapy at the Heidelberg Ion Therapy Center (HIT) – integrated research-driven university-hospital-based radiation oncology service in Heidelberg, Germany,’ Radiother. Oncol.95, 41–44.
80.
ComettoA., RussoG., BourhalebF., MilianF., GiordanengoS., MarchettoF., CirioR., and AttiliA. (2014). ‘Direct evaluation of radiobiological parameters from clinical data in the case of ion beam therapy: an alternative approach to the relative biological effectiveness,’ Phys. Med. Biol.59, 7393.
81.
ConstantinescuA., LehmannH.I., PackerD.L., BertC., DuranteM., and GraeffC. (2016). ‘Treatment planning studies in patient data with scanned carbon ion beams for catheter-free ablation of atrial fibrillation,’ J. Cardiovasc. Electrophysiol.27, 335–344.
82.
CuiY., DyJ.G., SharpG.C., AlexanderB., and JiangS.B. (2007). ‘Robust fluoroscopic respiratory gating for lung cancer radiotherapy without implanted fiducial markers,’ Phys. Med. Biol.52, 741–755.
83.
DawsonL.A., KavanaghB.D., PaulinoA.C., DasS.K., MiftenM., LiX.A., PanC., Ten HakenR.K., and SchultheissT.E. (2010). ‘Radiation-associated kidney injury,’ Int. J. Radiat. Oncol. Biol. Phys.76, S108–S115.
84.
DeutschmannH., NeunerM., SteiningerP., PinzgerM., BuckM., and SedlmayerF. (2013). ‘Robotic positioning and imaging,’ Strahlenther. Onkol.189, 185.
85.
DiasM.F., RiboldiM., SecoJ., CastelhanoI., PellaA., MirandolaA., PeraltaL., CioccaM., OrecchiaR., and BaroniG. (2015). ‘Scan path optimization with/without clustering for active beam delivery in charged particle therapy,’ Phys. Med.31, 130–136.
86.
DifferdingS., HaninF.X., and GregoireV. (2015). ‘PET imaging biomarkers in head and neck cancer,’ Eur. J. Nucl. Med. Mol. Imaging42, 613–622.
87.
DIN (2009). Deutsches Institut für Normung. Qualitätsmanagementsystem in der Medizinischen Radiologie – Teil 1: Strahlentherapie, DIN 6870-1:2009-02 (Beuth Verlag GmbH, Berlin).
DingfelderM. (2014). ‘Updated model for dielectric response function of liquid water,’ Appl. Radiat. Isot.83 Pt B, 142–147.
90.
DingfelderM., HantkeD., InokutiM., and ParetzkeH.G. (1998). ‘Electron inelastic-scattering cross sections in liquid water,’ Radiat. Phys. Chem.53, 1–18.
91.
DongY., GuanH., HuangW., ZhangZ., ZhaoD., LiuY., ZhouT., and LiB. (2015). ‘Precise delineation of clinical target volume for crossing-segments thoracic esophageal squamous cell carcinoma based on the pattern of lymph node metastases,’ J. Thorac. Dis.7, 2313–2320.
92.
DreherC., ScholzC., PommerM., BronsS., ProkeschH., EckerS., DebusJ., JäkelO., CombsS.E., and HabermehlD. (2016). ‘Optimization of carbon ion treatment plans by integrating tissue specific alpha/beta-values for patients with non-resectable pancreatic cancer,’ PLoS One11, e0164473.
93.
DuranteM., and LoefflerJ.S. (2010). ‘Charged particles in radiation oncology,’ Nat. Rev. Clin. Oncol.7:37–43.
94.
EbnerD.K., TsujiH., YasudaS., YamamotoN., MoriS., and KamadaT. (2017). ‘Respiration-gated fast-rescanning carbon-ion radiotherapy,’ Jpn. J. Clin. Oncol.47, 80–83.
EdmundJ.M., and NyholmT. (2017). ‘A review of substitute CT generation for MRI-only radiation therapy,’ Radiat. Oncol.12, 28–42.
97.
EickhoffH., HabererT., KraftG., KrauseU., RichterM., SteinerR., and DebusJ. (1999). ‘The GSI Cancer Therapy Project,’ Strahlenther. Onkol.175, 21–24.
98.
EleyJ.G., NewhauserW.D., LuchtenborgR., GraeffC., and BertC. (2014). ‘4D optimization of scanned ion beam tracking therapy for moving tumors,’ Phys. Med. Biol.59, 3431–3452.
99.
EleyJ.G., NewhauserW.D., RichterD., LuchtenborgR., SaitoN., and BertC. (2015). ‘Robustness of target dose coverage to motion uncertainties for scanned carbon ion beam tracking therapy of moving tumors,’ Phys. Med. Biol.60, 1717–1740.
100.
EllerbrockM., JäkelO., KrämerM., NikoghosyanA., and Schulz-ErtnerD. (2006). ‘Clinical implementation of multiple field dose optimization in heavy ion treatment planning,’ Radiother. Oncol.81, S358.
101.
EllerbrockM., JäkelO., KrämerM., NikoghosyanA., Schulz-ErtnerD., KargerC.P., AckermannB., HeegP., and DebusJ. (2008). ‘Clinical implementation of intensity modulated heavy ion therapy,’ Int. J. Radiat. Oncol.84, S592.
102.
ElsässerT., and ScholzM. (2007). ‘Cluster effects within the local effect model,’ Radiat. Res.167, 319–329.
103.
ElsässerT., KramerM., and ScholzM. (2008). ‘Accuracy of the local effect model for the prediction of biologic effects of carbon ion beams in vitro and in vivo,’ Int. J. Radiat. Oncol. Biol. Phys.71, 866–872.
104.
ElsässerT., WeyratherW.K., FriedrichT., DuranteM., IancuG., KramerM., KraglG., BronsS., WinterM., WeberK.J., and ScholzM. (2010). ‘Quantification of the relative biological effectiveness for ion beam radiotherapy: Direct experimental comparison of proton and carbon ion beams and a novel approach for treatment planning,’ Int. J. Radiat. Oncol. Biol. Phys.78, 1177–1183.
105.
EmfietzoglouD., Garcia-MolinaR., KyriakouI., AbrilI., and NikjooH. (2009). ‘A dielectric response study of the electronic stopping power of liquid water for energetic protons and a new I-value for water,’ Phys. Med. Biol.54, 3451–3472.
106.
EndoM., KoyamaitoH., MinoharaS., MiyaharaN., TomuraH., KanaiT., KawachiK., TsujiiH., and MoritaK. (1996). ‘HIPLAN – a heavy ion treatment planning system at HIMAC,’ J. Jpn. Soc. Ther. Radiol. Oncol.8, 231–238.
107.
EndoS., TanakaK., IshikawaM., HoshiM., OnizukaY., TakadaM., YamaguchiH., HayabuchiN., MaedaN., and ShizumaK. (2005). ‘Microdosimetric evaluation of the 400 MeV/ nucleon carbon beam at HIMAC,’ Med. Phys.32, 3843–3848.
108.
EnghardtW., FrommW.D., ManfrassP., and SchardtD. (1992). ‘Limited-angle 3D reconstruction of PET images for dose localization in light ion tumour therapy,’ Phys. Med. Biol.37, 791–798.
109.
EnghardtW., CrespoP., FiedlerF., HinzR., ParodiK., PawelkeJ., and PonischF. (2004a). ‘Charged hadron tumour therapy monitoring by means of PET,’ Nucl. Inst. Methods Phys. Res.A 525, 284–288.
110.
EnghardtW., ParodiK., CrespoP., FiedlerF., PawelkeJ., and PonischF. (2004b). ‘Dose quantification from in-beam positron emission tomography,’ Radiother. Oncol.73, S96–S98.
111.
EvansP.M. (2008). ‘Anatomical imaging for radiotherapy,’ Phys. Med. Biol.53, R151–R191.
112.
FattoriG., RiboldiM., PellaA., PeroniM., CerveriP., DesplanquesM., FontanaG., TagasteB., ValvoF., OrecchiaR., and BaroniG. (2015). ‘Image guided particle therapy in CNAO room 2: implementation and clinical validation,’ Phys. Med.31, 9–15.
113.
FeldmeierE., HabererT., PetersA., SchoemersC., and SteinerR. (2010). ‘Magnetic field correction in normal conducting synchrotrons,’ pp. 675–677 in Proc. IPAC'10 (CERN, Geneva).
114.
FiedlerF., PriegnitzM., JulichR., PawelkeJ., CrespoP., ParodiK., PonischF., and EnghardtW. (2008). ‘In-beam PET measurements of biological half-lives of 12C irradiation induced beta+-activity,’ Acta Oncol.47, 1077–1086.
115.
FlanzJ., JäkelO., FordE., HahnS., MazalA., and DaartzJ. (2016a). PTCOG Safety Group Report on Aspects of Safety in Particle Therapy: Version 2 (Particle Therapy Co-Operative Group, Boston). https://www.ptcog.ch/archive/Software_and_Docs/PTCOG_Safety_Report_2.pdf (21 December 2018, date last accessed).
116.
FlanzJ., LitzenbergD., ChenH., and SchreuderN. (2016b). PTCOG White Paper on Particle Therapy Efficiency: Aspects of Quality Assurance, Version 1 (Particle Therapy Co-Operative Group, Boston). https://www.ptcog.ch/archive/Software_and_Docs/White_Paper_QA_Efficiency.pdf (21 December 2018, date last accessed).
117.
FossatiP., MolinelliS., MatsufujiN., CioccaM., MirandolaA., MairaniA., MizoeJ., HasegawaA., ImaiR., KamadaT., OrecchiaR., and TsujiiH. (2012). ‘Dose prescription in carbon ion radiotherapy: a planning study to compare NIRS and LEM approaches with a clinically-oriented strategy,’ Phys. Med. Biol.57, 7543–7554.
118.
FraassB., DoppkeK., HuntM., KutcherG., StarkschallG., SternR., and Van DykeJ. (1998). ‘AAPM Radiation Therapy Committee Task Group 53: Quality assurance for clinical radiotherapy treatment planning,’ Med. Phys.25, 1773–1829.
119.
FredrikssonA., ForsgrenA., and HardemarkB. (2015). ‘Maximizing the probability of satisfying the clinical goals in radiation therapy treatment planning under setup uncertainty,’ Med. Phys.42, 3992–3999.
120.
FritzA., PercyC., JackA., ShanmugaratnamK., SobinL., ParkinD.M., and WhelanS. (2013). International Classification of Diseases for Oncology (World Health Organization, Geneva).
121.
FukahoriM., MatsufujiN., HimukaiT., KanematsuN., MizunoH., FukumuraA., TsujiH., and KamadaT. (2016). ‘Estimation of late rectal normal tissue complication probability parameters in carbon ion therapy for prostate cancer,’ Radiother. Oncol.118, 136–140.
122.
FukudaS., FurukawaT., and IwataY. (2014). ‘Beam-delivery systems,’ pp. 53–64 in Carbon-Ion Radiotherapy: Principles, Practices, and Treatment Planning, Tsujii, H., Kamada, T., Shirai, T., Noda, K., Tsuji, H., and Karasawa, K., Eds. (Springer, Tokyo, Japan).
FurukawaT., InaniwaT., SatoS., TomitaniT., MinoharaS., NodaK., and KanaiT. (2007). ‘Design study of a raster scanning system for moving target irradiation in heavy-ion radiotherapy,’ Med. Phys.34, 1085–1097.
125.
FurukawaT., SaotomeN., InaniwaT., SatoS., NodaK., and KanaiT. (2008). ‘Delivery verification using 3D dose reconstruction based on fluorescence measurement in a carbon beam scanning irradiation system,’ Med. Phys.35, 2235–2242.
126.
FurukawaT., InaniwaT., SatoS., ShiraiT., MoriS., TakeshitaE., MizushimaK., HimukaiT., and NodaK. (2010). ‘Moving target irradiation with fast rescanning and gating in particle therapy,’ Med. Phys.37, 4874–4879.
127.
FurusawaY., FukutsuK., AokiM., ItsukaichiH., Eguchi-KasaiK., OharaH., YatagaiF., KanaiT., and AndoK. (2000). ‘Inactivation of aerobic and hypoxic cells from three different cell lines by accelerated 3He-, 12C-and 20Ne-ion beams,’ Radiat. Res.154, 485–496.
128.
FutamiY., KanaiT., FujitaM., TomuraH., HigashiA., MatsufujiN., MiyaharaN., EndoM., and KawachiK. (1999). ‘Broad-beam three-dimensional irradiation system for heavy-ion radiotherapy at HIMAC,’ Nucl. Inst. Methods Phys. Res. A430, 143–153.
129.
GalerS., ShipleyD., PalmansH., KirkbyK., and NisbetA. (2017). ‘Monte Carlo simulation of a TEPC for microdosimetry of carbon ions,’ Radiat. Phys. Chem.140, 412–418.
130.
GalonskaM., ScheloskeS., CeeR., HöppnerK., WinkelmannT., PetersA., and HabererT. (2011). ‘Commissioning of the ion beam gantry at HIT,’ pp. 2874 to 2876 in Proc. IPAC2011: 2nd International Particle Accelerator Conference, https://accelconf.web.cern.ch/accelconf/IPAC2011/papers/thoab03.pdf (20 December 2018, date last accessed) (European Organization for Nuclear Research, Geneva).
131.
GeetsX., DaisneJ.F., TomsejM., DuprezT., LonneuxM., and GregoireV. (2006). ‘Impact of the type of imaging modality on target volumes delineation and dose distribution in pharyngo-laryngeal squamous cell carcinoma: comparison between pre- and per-treatment studies,’ Radiother. Oncol.78, 291–297.
132.
GeetsX., TomsejM., LeeJ.A., DuprezT., CocheE., CosnardG., LonneuxM., and GregoireV. (2007). ‘Adaptive biological image-guided IMRT with anatomic and functional imaging in pharyngo-laryngeal tumors: Impact on target volume delineation and dose distribution using helical tomotherapy,’ Radiother. Oncol.85, 105–115.
133.
GeithnerO., AndreoP., SobolevskyN., HartmannG., and JäkelO. (2006). ‘Calculation of stopping power ratios for carbon ion dosimetry,’ Phys. Med. Biol.51, 2279–2292.
134.
GemmelA., HaschB., EllerbrockM., WeyratherW.K., and KramerM. (2008). ‘Biological dose optimization with multiple ion fields,’ Phys. Med. Biol.53, 6991–7012.
135.
GhadjarP., Schreiber-FacklamH., GraterR., EversC., SimcockM., GeretschlagerA., BlumsteinN.M., ZbarenP., ZimmerY., WilkensL., and AebersoldD.M. (2010). ‘Quantitative analysis of extracapsular extension of metastatic lymph nodes and its significance in radiotherapy planning in head and neck squamous cell carcinoma,’ Int. J. Radiat. Oncol. Biol. Phys.76, 1127–1132.
136.
GlowaC., KargerC.P., BronsS., ZhaoD., MasonR.P., HuberP.E., DebusJ., and PeschkeP. (2016). ‘Carbon ion radiotherapy decreases the impact of tumor heterogeneity on radiation response in experimental prostate tumors,’ Cancer Lett.378, 97–103.
137.
Gol'dinL., DzhelepovV., LomanovM., SavchenkoO., and KhoroshkovV.S. (1973). ‘Application of high-energy heavy charged particles in medicine,’ Phys.-Uspekhi16, 402–413.
138.
GoldhaberA.S., and HeckmanH.H. (1978). ‘High-energy interactions of nuclei,’ Annu. Rev. Nucl. Part. Sci.28, 161–205.
139.
GomaC., AndreoP., and SempauJ. (2013). ‘Spencer-Attix water/medium stopping-power ratios for the dosimetry of proton pencil beams,’ Phys. Med. Biol.58, 2509–2522.
GottschalkB. (2010). ‘On the scattering power of radiotherapy protons,’ Med. Phys.37, 352–367.
142.
GoughR.A. (1987). ‘The Light Ion Biomedical Research Accelerator (LIBRA),’ pp. 117 to 125 in Proc. 5thPTCOG Meeting and International Workshop on Biomedical Accelerators, LBL-22962 (National Technical Information Service, Springfield, Virginia).
143.
GraeffC. (2017). ‘Robustness of 4D-optimized scanned carbon ion beam therapy against interfractional changes in lung cancer,’ Radiother. Oncol.122, 387–392.
144.
GraeffC., DuranteM., and BertC. (2012). ‘Motion mitigation in intensity modulated particle therapy by internal target volumes covering range changes,’ Med. Phys.39, 6004–6013.
145.
GraeffC., ConstantinescuA., LuchtenborgR., DuranteM., and BertC. (2014). ‘Multigating, a 4D optimized beam tracking in scanned ion beam therapy,’ Technol. Cancer Res. Treat.13, 497–504.
146.
GraffmanS., BrahmeA., and LarssonB. (1985). ‘Proton radiotherapy with the Uppsala cyclotron. Experience and plans,’ Strahlentherapie161, 764–770.
147.
GrecaV. (2018). Therapeutic Particles [online], CERN Courier, https://cerncourier.com/therapeutic-particles/ (December 16 2018, date last accessed) (IOP Publishing, Bristol, United Kingdom).
148.
GrégoireV., CocheE., CosnardG., HamoirM., and ReychlerH. (2000). ‘Selection and delineation of lymph node target volumes in head and neck conformal radiotherapy. Proposal for standardizing terminology and procedure based on the surgical experience,’ Radiother. Oncol.56, 135–150.
149.
GrégoireV., PötterR., and WambersieA. (2004). ‘General principles for prescribing, recording and reporting a therapeutic irradiation,’ Radiother. Oncol.73, S57–S61.
150.
GrégoireV., JerajR., LeeJ.A., and O'SullivanB. (2012). ‘Radiotherapy for head and neck tumours in 2012 and beyond: Conformal, tailored, and adaptive?,’ Lancet Oncol.13, e292–e300.
151.
GrégoireV., ScallietP., and AngK. (2013). Clinical Target Volumes in Conformal and Intensity Modulated Radiation Therapy: A Clinical Guide to Cancer Treatment (Springer Science & Business Media, Berlin).
152.
GrégoireV., AngK., BudachW., GrauC., HamoirM., LangendijkJ.A., LeeA., LeQ.T., MaingonP., NuttingC., O'SullivanB., PorcedduS.V., and LengeleB. (2014). ‘Delineation of the neck node levels for head and neck tumors: A 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines,’ Radiother. Oncol.110, 172–181.
153.
GrozingerS.O., RietzelE., LiQ., BertC., HabererT., and KraftG. (2006). ‘Simulations to design an online motion compensation system for scanned particle beams,’ Phys. Med. Biol.51, 3517–3531.
154.
GrozingerS.O., BertC., HabererT., KraftG., and RietzelE. (2008). ‘Motion compensation with a scanned ion beam: a technical feasibility study,’ Radiat. Oncol.3, 34.
155.
GrünR., FriedrichT., KramerM., ZinkK., DuranteM., Engenhart-CabillicR., and ScholzM. (2015). ‘Assessment of potential advantages of relevant ions for particle therapy: a model based study,’ Med. Phys.42, 1037–1047.
156.
GrunderH., HartsoughW., and LofgrenE. (1971). ‘Acceleration of heavy ions at the Bevatron,’ Science174, 1128–1129.
157.
GuanF., PeelerC., BronkL., GengC., TaleeiR., RandeniyaS., GeS., MirkovicD., GrosshansD., and MohanR. (2015). ‘Analysis of the track‐and dose‐averaged LET and LET spectra in proton therapy using the geant4 Monte Carlo code,’ Med. Phys.42, 6234–6247.
158.
GudowskaI., SobolevskyN., AndreoP., BelkicD., and BrahmeA. (2004). ‘Ion beam transport in tissue-like media using the Monte Carlo code SHIELD-HIT,’ Phys. Med. Biol.49, 1933–1958.
159.
GueuletteJ., Octave-PrignotM., De CosteraB.M., WambersieA., and GregoireV. (2004). ‘Intestinal crypt regeneration in mice: a biological system for quality assurance in non-conventional radiation therapy,’ Radiother. Oncol.73, S148–S154.
160.
GueuletteJ., BlattmannH., PedroniE., CorayA., De CosterB.M., MahyP., WambersieA., and GoiteinG. (2005). ‘Relative biologic effectiveness determination in mouse intestine for scanning proton beam at Paul Scherrer Institute, Switzerland. influence of motion,’ Int. J. Radiat. Oncol. Biol. Phys.62, 838–845.
161.
Gunzert-MarxK., SchardtD., and SimonR.S. (2004). ‘Fast neutrons produced by nuclear fragmentation in treatment irradiations with 12C beam,’ Radiat. Prot. Dosimetry110, 595–600.
162.
Gunzert-MarxK., IwaseH., SchardtD., and SimonR. (2008). ‘Secondary beam fragments produced by 200 MeV u−1 12C ions in water and their dose contributions in carbon ion radiotherapy,’ New J. Phys.10, 075003.
163.
GwoschK., HartmannB., JakubekJ., GranjaC., SoukupP., JäkelO., and MartisikovaM. (2013). ‘Non-invasive monitoring of therapeutic carbon ion beams in a homogeneous phantom by tracking of secondary ions,’ Phys. Med. Biol.58, 3755–3773.
164.
HabererT., BecherW., SchardtD., and KraftG. (1993). ‘Magnetic scanning system for heavy-ion therapy,’ Nucl. Instrum. Methods Phys. Res. A330, 296–305.
165.
HabererT., DebusJ., EickhoffH., JäkelO., Schulz-ErtnerD., and WeberU. (2004). ‘The Heidelberg Ion Therapy Center,’ Radiother. Oncol.73, S186–S190.
166.
HabermehlD., DebusJ., GantenT., GantenM.-K., BauerJ., BrechtI.C., BronsS., HabererT., HaertigM., and JäkelO. (2013a). ‘Hypofractionated carbon ion therapy delivered with scanned ion beams for patients with hepatocellular carcinoma–feasibility and clinical response,’ Radiat. Oncol.8, 59.
167.
HabermehlD., HenknerK., EckerS., JäkelO., DebusJ., and CombsS.E. (2013b). ‘Evaluation of different fiducial markers for image-guided radiotherapy and particle therapy,’ J. Radiat. Res.54, i61–i68.
168.
HablG., UhlM., KatayamaS., KesselK.A., HatibogluG., HadaschikB., EdlerL., TichyD., EllerbrockM., HabererT., WolfM.B., SchlemmerH.P., DebusJ., and HerfarthK. (2016). ‘Acute toxicity and quality of life in patients with prostate cancer treated with protons or carbon ions in a prospective randomized phase II study – the IPI Trial,’ Int. J. Radiat. Oncol. Biol. Phys.95, 435–443.
169.
HaettnerE., IwaseH., KrämerM., KraftG., and SchardtD. (2013). ‘Experimental study of nuclear fragmentation of 200 and 400 MeV/u 12C ions in water for applications in particle therapy,’ Phys. Med. Biol.58, 8265.
170.
HanleyJ., DeboisM.M., MahD., MagerasG.S., RabenA., RosenzweigK., MychalczakB., SchwartzL.H., GloegglerP.J., LutzW., LingC.C., LeibelS.A., FuksZ., and KutcherG.J. (1999). ‘Deep inspiration breath-hold technique for lung tumors: the potential value of target immobilization and reduced lung density in dose escalation,’ Int. J. Radiat. Oncol. Biol. Phys.45, 603–611.
171.
HaraY., FurukawaT., InaniwaT., MizushimaK., ShiraiT., and NodaK. (2014). ‘A novel method for experimental characterization of large-angle scattered particles in scanned carbon-ion therapy,’ Med. Phys.41, 021706.
172.
HaraY., FurukawaT., MizushimaK., InaniwaT., SaotomeN., TanshoR., SarayaY., ShiraiT., and NodaK. (2017). ‘Commissioning of full energy scanning irradiation with carbon-ion beams ranging from 55.6 to 430 MeV/u at the NIRS-HIMAC,’ Nucl. Instrum. Methods Phys. Res. B406, 343–346.
173.
HarrisV.A., StaffurthJ., NaismithO., EsmailA., GullifordS., KhooV., LewisR., LittlerJ., McNairH., SadoyzeA., ScraseC., SohaibA., SyndikusI., ZarkarA., HallE., DearnaleyD., and TrialistsP. (2015). ‘Consensus guidelines and contouring atlas for pelvic node delineation in prostate and pelvic node intensity modulated radiation therapy,’ Int. J. Radiat. Oncol. Biol. Phys.92, 874–883.
174.
HartmannG.H., JäkelO., HeegP., KargerC.P., and KriessbachA. (1999). ‘Determination of water absorbed dose in a carbon ion beam using thimble ionization chambers,’ Phys. Med. Biol.44, 1193–1206.
175.
HartmannB., TelsemeyerJ., HuberL., AckermannB., JäkelO., and MartisikovaM. (2012). ‘Investigations of a flat-panel detector for quality assurance measurements in ion beam therapy,’ Phys. Med. Biol.57, 51–68.
176.
HasegawaA., MizoeJ.E., MizotaA., and TsujiiH. (2006). ‘Outcomes of visual acuity in carbon ion radiotherapy: analysis of dose-volume histograms and prognostic factors,’ Int. J. Radiat. Oncol. Biol. Phys.64, 396–401.
177.
HawkinsR.B. (1994). ‘A statistical theory of cell killing by radiation of varying linear energy transfer,’ Radiat. Res.140, 366–374.
178.
HawkinsR.B. (1996). ‘A microdosimetric-kinetic model of cell death from exposure to ionizing radiation of any LET, with experimental and clinical applications,’ Int. J. Radiat. Biol.69, 739–755.
179.
HeilandM., SchulzeD., BlakeF., and SchmelzleR. (2005). ‘Intraoperative imaging of zygomaticomaxillary complex fractures using a 3D C-arm system,’ Int. J. Oral Maxillofac. Surg.34, 369–375.
180.
HeilbronJ.L., and SeidelR.W. (1989). Lawrence and his Labroratory: A History of the Lawrence Berkeley Laboratory (University of California Press, Berkeley).
181.
HendersonF.C., McCoolK., SeigleJ., JeanW., HarterW., and GagnonG.J. (2009). ‘Treatment of chordomas with cyberknife: Georgetown University experience and treatment recommendations,’ Neurosurgery64, A44–A53.
182.
HenknerK., BasslerN., SobolevskyN., and JäkelO. (2009). ‘Monte Carlo simulations on the water-to-air stopping power ratio for carbon ion dosimetry,’ Med. Phys.36, 1230–1235.
183.
HenknerK., WinterM., EchnerG., AckermannB., BronsS., HornJ., JäkelO., and KargerC.P. (2015). ‘A motorized solid-state phantom for patient-specific dose verification in ion beam radiotherapy,’ Phys. Med. Biol.60, 7151–7163.
184.
HermanekP., WittekindC., and AltendorfhofmannA. (1994). ‘Uicc classification of pancreatic ductal adenocarcinoma,’ Int. J. Pancreatol.16230–232.
185.
HildS., GraeffC., RucinskiA., ZinkK., HablG., DuranteM., HerfarthK., and BertC. (2016). ‘Scanned ion beam therapy for prostate carcinoma: Comparison of single plan treatment and daily plan-adapted treatment,’ Strahlenther. Onkol.192, 118–126.
186.
HiramotoK., and NishiM. (1992). ‘Resonant beam extraction scheme with constant separatrix,’ Nucl. Instrum. Methods Phys. Res. A322, 154–160.
187.
HockelM., HornL.C., TetschE., and EinenkelJ. (2012). ‘Pattern analysis of regional spread and therapeutic lymph node dissection in cervical cancer based on ontogenetic anatomy,’ Gynecol. Oncol.125, 168–174.
188.
HofH., HerfarthK.K., MunterM., HoessA., MotschJ., WannenmacherM., and DebusJ.J. (2003). ‘Stereotactic single-dose radiotherapy of stage I non-small-cell lung cancer (NSCLC),’ Int. J. Radiat. Oncol. Biol. Phys.56, 335–341.
189.
HojoS., HonmaT., SakamotoY., and YamadaS. (2005). ‘Production of 11C-beam for particle therapy,’ Nucl. Instrum. Methods Phys. Res. B240, 75–78.
190.
HongL., GoiteinM., BuccioliniM., ComiskeyR., GottschalkB., RosenthalS., SeragoC., and UrieM. (1996). ‘A pencil beam algorithm for proton dose calculations,’ Phys. Med. Biol.41, 1305–1330.
191.
HornseyS. (1991). ‘Experimental central nervous system injury from fast neutrons,’ pp. 137–148 in Radiation Injury to the Nervous System, Gutin P.H, Leibel S.A, and Sheline G.E., Eds. (Raven Press, New York).
192.
HouwelingA.C., FukataK., KubotaY., ShimadaH., RaschC.R., OhnoT., BelA., and van der HorstA. (2016). ‘The impact of interfractional anatomical changes on the accumulated dose in carbon ion therapy of pancreatic cancer patients,’ Radiother. Oncol.119, 319–325.
193.
HuaC., LovelockD.M., MagerasG.S., KatzM.S., MechalakosJ., LiefE.P., HollisterT., LutzW.R., ZelefskyM.J., and LingC.C. (2003). ‘Development of a semi-automatic alignment tool for accelerated localization of the prostate,’ Int. J. Radiat. Oncol. Biol. Phys.55, 811–824.
194.
HugoG.D., and RosuM. (2012). ‘Advances in 4D radiation therapy for managing respiration: Part I – 4D imaging,’ Z. Med. Phys.22, 258–271.
195.
HünemohrN., PaganettiH., GreilichS., JäkelO., and SecoJ. (2014). ‘Tissue decomposition from dual energy CT data for MC based dose calculation in particle therapy,’ Med. Phys.41, 061714.
196.
HuqM.S., FraassB.A., DunscombeP.B., GibbonsJ.P., IbbottG.S., MundtA.J., MuticS., PaltaJ.R., RathF., and ThomadsenB.R. (2016). ‘The report of Task Group 100 of the AAPM: application of risk analysis methods to radiation therapy quality management,’ Med. Phys.43, 4209–4262.
197.
IAEA (2000). International Atomic Energy Agency. Absorbed Dose Determination in External Beam Radiotherapy: An International Code of Practice for Dosimetry Based on Standards of Absorbed Dose to Water, IAEA TRS-398 (International Atomic Energy Agency, Vienna).
198.
IAEA (2004). International Atomic Energy Agency. Commissioning and Quality Assurance of Computerized Planning Systems for Radiation Treatment of Cancer, IAEA TRS-340 (International Atomic Energy Agency, Vienna).
199.
IAEA (2007a). International Atomic Energy Agency. Dose Reporting in Ion Beam Therapy, IAEA TECDOC-1560 (International Atomic Energy Agency, Vienna).
200.
IAEA (2007b). International Atomic Energy Agency. Specification and Acceptance Testing of Radiotherapy Treatment Planning Systems, IAEA TECDOC-1540 (International Atomic Energy Agency, Vienna).
201.
IAEA (2008). International Atomic Energy Agency. Relative Biological Effectiveness in Ion Beam Therapy, Technical Reports Series No. 461 (International Atomic Energy Agency, Vienna).
202.
ICRP (2014). International Commission on Radiological Protection. Radiological Protection in Ion Beam Radiotherapy, ICRP Publication 127, Ann. ICRP 43 (Sage Publications, Thousand Oaks, California).
203.
ICRU (1970). International Commission on Radiation Units and Measurements. Linear Energy Transfer. ICRU Report 16 (International Commission on Radiation Units and Measurements, Bethesda, Maryland).
204.
ICRU (1979). International Commission on Radiation Units and Measurements. Quantitative Concepts and Dosimetry in Radiobiology. ICRU Report 30 (International Commission on Radiation Units and Measurements, Bethesda, Maryland).
205.
ICRU (1983). International Commission on Radiation Units and Measurements. Microdosimetry. ICRU Report 36 (International Commission on Radiation Units and Measurements, Bethesda, Maryland).
206.
ICRU (1984). International Commission on Radiation Units and Measurements. Stopping Powers for Electrons and Positrons. ICRU Report 37 (International Commission on Radiation Units and Measurements, Bethesda, Maryland).
207.
ICRU (1986). International Commission on Radiation Units and Measurements. The Quality Factor in Radiation Protection. ICRU Report 40 (International Commission on Radiation Units and Measurements, Bethesda, Maryland).
208.
ICRU (1993a). International Commission on Radiation Units and Measurements. Stopping Powers and Ranges for Protons and Alpha Particles. ICRU Report 49 (International Commission on Radiation Units and Measurements, Bethesda, Maryland).
209.
ICRU (1993b). International Commission on Radiation Units and Measurements. Prescribing, Recording and Reporting Photon Beam Therapy. ICRU Report50 (International Commission on Radiation Units and Measurements, Bethesda, MD Maryland).
210.
ICRU (1998). International Commission on Radiation Units and Measurements. Clinical Proton Dosimetry Part I: Beam Production, Beam Delivery and Measurement of Absorbed Dose. ICRU Report 59 (International Commission on Radiation Units and Measurements, Bethesda, Maryland).
211.
ICRU (1999). International Commission on Radiation Units and Measurements. Prescribing, Recording and Reporting Photon Beam Therapy (Supplement to ICRU Report 50). ICRU Report 62 (International Commission on Radiation Units and Measurements, Bethesda, Maryland).
212.
ICRU (2004). International Commission on Radiation Units and Measurements. ‘Prescribing, recording, and reporting electron beam therapy,’ ICRU Report 71, J. ICRU 4(1).
213.
ICRU (2005). International Commission on Radiation Units and Measurements. ‘Stopping of ions heavier than helium,’ ICRU Report 73, J. ICRU 5(1).
214.
ICRU (2007). International Commission on Radiation Units and Measurements. ‘Prescribing, recording, and reporting proton-beam therapy,’ ICRU Report 78, J. ICRU 7(2).
215.
ICRU (2009). International Commission on Radiation Units and Measurements. ‘Errata and addenda for ICRU Report 73, stopping of ions heavier than helium,’ ICRU Report 73, J. ICRU 5(1).
216.
ICRU (2010). International Commission on Radiation Units and Measurements. ‘Prescribing, recording and reporting photon-beam intensity-modulated radiation therapy,’ ICRU Report 83, J. ICRU 10(1).
217.
ICRU (2011). International Commission on Radiation Units and Measurements. ‘Fundamental quantities and units for ionizing radiation,’ ICRU Report 85, J. ICRU 11(1).
218.
ICRU (2014). International Commission on Radiation Units and Measurements. ‘Key data for ionizing-radiation dosimetry: Measurement standards and applications,’ ICRU Report 90, J. ICRU 14(1).
219.
IEC (2007). International Electrotechnical Commission. Medical Electrical Equipment – Medical Electron Accelerators – Functional Performance Characteristics, IEC 60976:2007 (International Electrotechnical Commission, Geneva).
220.
IEC (2014). International Electrotechnical Commission. Medical Electrical Equipment – Part 2-64: Particular Requirements for the Basic Safety and Essential Performance of Light Ion Beam Medical Electrical Equipment, IEC 60601-2-64:2014 (International Electrotechnical Commission, Geneva).
221.
InaniwaT., KohnoT., TomitaniT., UrakabeE., SatoS., KanazawaM., and KanaiT. (2006). ‘Experimental determination of particle range and dose distribution in thick targets through fragmentation reactions of stable heavy ions,’ Phys. Med. Biol.51, 4129–4146.
222.
InaniwaT., FurukawaT., MatsufujiN., KohnoT., SatoS., NodaK., and KanaiT. (2007a). ‘Clinical ion beams: semi-analytical calculation of their quality,’ Phys. Med. Biol.52, 7261.
223.
InaniwaT., FurukawaT., TomitaniT., SatoS., NodaK., and KanaiT. (2007b). ‘Optimization for fast‐scanning irradiation in particle therapy,’ Med. Phys.34, 3302–3311.
224.
InaniwaT., KohnoT., TomitaniT., and SatoS. (2008). ‘Monitoring the irradiation field of 12C and 16O SOBP beams using positron emitters produced through projectile fragmentation reactions,’ Phys. Med. Biol.53, 529–542.
225.
InaniwaT., FurukawaT., KaseY., MatsufujiN., ToshitoT., MatsumotoY., FurusawaY., and NodaK. (2010). ‘Treatment planning for a scanned carbon beam with a modified microdosimetric kinetic model,’ Phys. Med. Biol.55, 6721–6737.
226.
InaniwaT., KanematsuN., FurukawaT., and HasegawaA. (2011). ‘A robust algorithm of intensity modulated proton therapy for critical tissue sparing and target coverage,’ Phys. Med. Biol.56, 4749–4770.
227.
InaniwaT., FurukawaT., KanematsuN., MoriS., MizushimaK., SatoS., ToshitoT., ShiraiT., and NodaK. (2012). ‘Evaluation of hybrid depth scanning for carbon-ion radiotherapy,’ Med. Phys.39, 2820–2825.
228.
InaniwaT., KanematsuN., HaraY., FurukawaT., FukahoriM., NakaoM., and ShiraiT. (2014a). ‘Implementation of a triple Gaussian beam model with subdivision and redefinition against density heterogeneities in treatment planning for scanned carbon-ion radiotherapy,’ Phys. Med. Biol.59, 5361–5386.
229.
InaniwaT., KanematsuN., HaraY., and FurukawaT. (2014b). ‘Nuclear-interaction correction of integrated depth dose in carbon-ion radiotherapy treatment planning,’ Phys. Med. Biol.60, 421.
230.
InaniwaT., KanematsuN., MatsufujiN., KanaiT., ShiraiT., NodaK., TsujiH., KamadaT., and TsujiiH. (2015a). ‘Reformulation of a clinical-dose system for carbon-ion radiotherapy treatment planning at the National Institute of Radiological Sciences, Japan,’ Phys. Med. Biol.60, 3271–3286.
231.
InaniwaT., KanematsuN., TsujiH., and KamadaT. (2015b). ‘Influence of nuclear interactions in body tissues on tumor dose in carbon-ion radiotherapy,’ Med. Phys.42, 7132–7137.
232.
InaniwaT., and KanematsuN. (2015c). ‘A trichrome beam model for biological dose calculation in scanned carbon-ion radiotherapy treatment planning,’ Phys. Med. Biol.60, 437.
233.
IsekiY., KanaiT., KanazawaM., KitagawaA., MizunoH., TomitaniT., SudaM., and UrakabeE. (2004). ‘Range verification system using positron emitting beams for heavy-ion radiotherapy,’ Phys. Med. Biol.49, 3179–3195.
234.
IwataY., YamadaS., MurakamiT., FujimotoT., FujisawaT., OgawaH., MiyaharaN., YamamotoK., HojoS., SakamotoY., MuramatsuM., TakeuchiT., MitsumotoT., TsutsuiH., WatanabeT., and UedaT. (2006). ‘Alternating-phase-focused IH-DTL for an injector of heavy-ion medical accelerators,’ Nucl. Instrum. Methods Phys. Res. A569, 685–696.
235.
IwataY., KadowakiT., UchiyamaH., FujimotoT., TakadaE., ShiraiT., FurukawaT., MizushimaK., TakeshitaE., KatagiriK., SatoS., SanoY., and NodaK. (2010). ‘Multiple-energy operation with extended flattops at HIMAC,’ Nucl. Instrum. Methods Phys. Res. A624, 33–38.
236.
JaffrayD.A., SiewerdsenJ.H., WongJ.W., and MartinezA.A. (2002). ‘Flat-panel cone-beam computed tomography for image-guided radiation therapy,’ Int. J. Radiat. Oncol. Biol. Phys.53, 1337–1349.
237.
JäkelO. (2006). ‘Ranges of ions in metals for use in particle treatment planning,’ Phys. Med. Biol.51, N173–N177.
238.
JäkelO. (2014). ‘Light-ion radiation therapy planning,’ pp. 487–504 in Comprehensive Biomedical Physics, Brahme, A., Ed. (Elsevier, Amsterdam).
239.
JäkelO., and ReissP. (2007). ‘The influence of metal artefacts on the range of ion beams,’ Phys. Med. Biol.52, 635–644.
240.
JäkelO., HartmannG.H., HeegP., and SchardtD. (2000a). ‘Effective point of measurement of cylindrical ionization chambers for heavy charged particles,’ Phys. Med. Biol.45, 599–607.
241.
JäkelO., HartmannG.H., KargerC.P., HeegP., and RassowJ. (2000b). ‘Quality assurance for a treatment planning system in scanned ion beam therapy,’ Med. Phys.27, 1588–1600.
242.
JäkelO., JacobC., SchardtD., KargerC.P., and HartmannG.H. (2001a). ‘Relation between carbon ion ranges and x-ray CT numbers,’ Med. Phys.28, 701–703.
243.
JäkelO., KramerM., KargerC.P., and DebusJ. (2001b). ‘Treatment planning for heavy ion radiotherapy: clinical implementation and application,’ Phys. Med. Biol.46, 1101–1116.
244.
JäkelO., HartmannG.H., KargerC.P., HeegP., and VatnitskyS. (2004). ‘A calibration procedure for beam monitors in a scanned beam of heavy charged particles,’ Med. Phys.31, 1009–1013.
245.
JäkelO., Schulz-ErtnerD., and DebusJ. (2007). ‘Specifying carbon ion doses for radiotherapy: the heidelberg approach,’ J. Radiat. Res.48, A87–A95.
246.
JensenA.D., WinterM., KuhnS.P., DebusJ., NairzO., and MunterM.W. (2012). ‘Robotic-based carbon ion therapy and patient positioning in 6 degrees of freedom: setup accuracy of two standard immobilization devices used in carbon ion therapy and IMRT,’ Radiat. Oncol.7, 51.
247.
JohnsonR.P., BashkirovV., DeWittL., GiacomettiV., HurleyR.F., PiersimoniP., PlautzT.E., SadrozinskiH.F.W., SchubertK., and SchulteR. (2016). ‘A fast experimental scanner for proton CT: technical performance and first experience with phantom scans,’ IEEE Trans. Nucl. Sci.63, 52–60.
248.
JongenY., KleevenW., ZarembaS., VandeplasscheD., BeeckmanW., AleksandrovV., KaramyshevaG., KazarinovN.Y., KianI., KostrominS., MorozovN., SamsonovE., ShirkovG., ShevtsovV., and SyresinE. (2006). ‘Design studies of the compact superconducting cyclotron for hadron therapy,’ pp. 1678–1680 in Proc. EPAC 2006 (European Physical Society Accelerator Group, Mulhouse, France).
249.
KaderkaR., SchardtD., DuranteM., BergerT., RammU., LicherJ., and La TessaC. (2012). ‘Out-of-field dose measurements in a water phantom using different radiotherapy modalities,’ Phys. Med. Biol.57, 5059–5074.
250.
KamadaT., TsujiiH., MizoeJ.E., MatsuokaY., TsujiH., OsakaY., MinoharaS., MiyaharaN., EndoM., and KanaiT. (1999). ‘A horizontal CT system dedicated to heavy-ion beam treatment,’ Radiother. Oncol.50, 235–237.
251.
KanaiT., KawachiK., MatsuzawaH., and InadaT. (1983). ‘Broad beam three-dimensional irradiation for proton radiotherapy,’ Med. Phys.10, 344–346.
252.
KanaiT., FurusawaY., FukutsuK., ItsukaichiH., Eguchi-KasaiK., and OharaH. (1997). ‘Irradiation of mixed beam and design of spread-out Bragg peak for heavy-ion radiotherapy,’ Radiat. Res.147, 78–85.
253.
KanaiT., EndoM., MinoharaS., MiyaharaN., Koyama-itoH., TomuraH., MatsufujiN., FutamiY., FukumuraA., HiraokaT., FurusawaY., AndoK., SuzukiM., SogaF., and KawachiK. (1999). ‘Biophysical characteristics of HIMAC clinical irradiation system for heavy-ion radiation therapy,’ Int. J. Radiat. Oncol. Biol. Phys.44, 201–210.
254.
KanaiT., FukumuraA., KusanoY., ShimboM., and NishioT. (2004). ‘Cross-calibration of ionization chambers in proton and carbon beams,’ Phys. Med. Biol.49, 771–781.
255.
KanazawaM., KitagawaA., KoudaS., NishioT., TorikoshiA., NodaK., MurakamiT., SudaM., TomitaniT., KanaiT., FutamiY., ShinboM., UrakabeE., and IsekiY. (2002). ‘Application of an RI-beam for cancer therapy: In-vivo verification of the ion-beam range by means of positron imaging,’ Nucl. Phys. A701, 244c–252c.
256.
KanematsuN. (2009). ‘Semi-empirical formulation of multiple scattering for the Gaussian beam model of heavy charged particles stopping in tissue-like matter,’ Phys. Med. Biol.54, N67–N73.
257.
KanematsuN., EndoM., FutamiY., KanaiT., AsakuraH., OkaH., and YusaK. (2002). ‘Treatment planning for the layer-stacking irradiation system for three-dimensional conformal heavy-ion radiotherapy,’ Med. Phys.29, 2823–2829.
258.
KanematsuN., MatsufujiN., KohnoR., MinoharaS., and KanaiT. (2003). ‘A CT calibration method based on the polybinary tissue model for radiotherapy treatment planning,’ Phys. Med. Biol.48, 1053–1064.
259.
KanematsuN., TorikoshiM., MizotaM., and KanaiT. (2007). ‘Secondary range shifting with range compensator for reduction of beam data library in heavy-ion radiotherapy,’ Med. Phys.34, 1907–1910.
260.
KanematsuN., InaniwaT., and NakaoM. (2016). ‘Modeling of body tissues for Monte Carlo simulation of radiotherapy treatments planned with conventional x-ray CT systems,’ Phys. Med. Biol.61, 5037–5050.
261.
KantemirisI., KaraiskosP., PapagiannisP., and AngelopoulosA. (2011). ‘Dose and dose averaged LET comparison of 1H, 4He, 6Li, 8Be, 10B, 12C, 14N, and 16O ion beams forming a spread‐out Bragg peak,’ Med. Phys.38, 6585–6591.
262.
KardarL., LiY., LiX., LiH., CaoW., ChangJ.Y., LiaoL., ZhuR.X., SahooN., GillinM., LiaoZ., KomakiR., CoxJ.D., LimG., and ZhangX. (2014). ‘Evaluation and mitigation of the interplay effects of intensity modulated proton therapy for lung cancer in a clinical setting,’ Pract. Radiat. Oncol.4, e259–e268.
263.
KargerC.P., JäkelO., and HartmannG.H. (1999). ‘A system for three-dimensional dosimetric verification of treatment plans in intensity-modulated radiotherapy with heavy ions,’ Med. Phys.26, 2125–2132.
264.
KargerC.P., HartmannG.H., JäkelO., and HeegP. (2000). ‘Quality management of medical physics issues at the German heavy ion therapy project,’ Med. Phys.27, 725–736.
265.
KargerC.P., JäkelO., DebusJ., KuhnS., and HartmannG.H. (2001a). ‘Three-dimensional accuracy and interfractional reproducibility of patient fixation and positioning using a stereotactic head mask system,’ Int. J. Radiat. Oncol. Biol. Phys.49, 1493–1504.
266.
KargerC.P., HartmannG.H., HeegP., and JäkelO. (2001b). ‘A method for determining the alignment accuracy of the treatment table axis at an isocentric irradiation facility,’ Phys. Med. Biol.46, N19–N26.
267.
KargerC.P., PeschkeP., Sanchez-BrandelikR., ScholzM., and DebusJ. (2006). ‘Radiation tolerance of the rat spinal cord after 6 and 18 fractions of photons and carbon ions: experimental results and clinical implications,’ Int. J. Radiat. Oncol. Biol. Phys.66, 1488–1497.
268.
KargerC.P., JäkelO., PalmansH., and KanaiT. (2010). ‘Dosimetry for ion beam radiotherapy,’ Phys. Med. Biol.55, R193–R234.
269.
KargerC.P., PeschkeP., ScholzM., HuberP.E., and DebusJ. (2013). ‘Relative biological effectiveness of carbon ions in a rat prostate carcinoma in vivo: comparison of 1, 2, and 6 fractions,’ Int. J. Radiat. Oncol. Biol. Phys.86, 450–455.
270.
KaseY., KanaiT., MatsumotoY., FurusawaY., OkamotoH., AsabaT., SakamaM., and ShinodaH. (2006a). ‘Microdosimetric measurements and estimation of human cell survival for heavy-ion beams,’ Radiat. Res.166, 629–638.
271.
KaseY., KanematsuN., KanaiT., and MatsufujiN. (2006b). ‘Biological dose calculation with Monte Carlo physics simulation for heavy-ion radiotherapy,’ Phys. Med. Biol.51, N467–N475.
272.
KaseY., KanaiT., MatsufujiN., FurusawaY., ElsässerT., and ScholzM. (2007). ‘Biophysical calculation of cell survival probabilities using amorphous track structure models for heavy-ion irradiation,’ Phys. Med. Biol.53, 37.
273.
KaseY., KanaiT., SakamaM., TameshigeY., HimukaiT., NoseH., and MatsufujiN. (2011). ‘Microdosimetric approach to NIRS-defined biological dose measurement for carbon-ion treatment beam,’ J. Radiat. Res.52, 59–68.
274.
KatoS., OhnoT., TsujiiH., NakanoT., MizoeJ.E., KamadaT., MiyamotoT., TsujiH., KatoH., YamadaS., KandatsuS., YoshikawaK., EzawaH., and SuzukiM.Working Group of the Gynecological Tumor. (2006). ‘Dose escalation study of carbon ion radiotherapy for locally advanced carcinoma of the uterine cervix,’ Int. J. Radiat. Oncol. Biol. Phys.65, 388–397.
275.
KatzR., AckersonB., HomayoonfarM., and SharmaS.C. (1971). ‘Inactivation of cells by heavy ion bombardment,’ Radiat. Res.47, 402–425.
KeallP. (2011). ‘Locating and targeting moving tumors with radiation beams,’ Front. Radiat. Ther. Oncol.43, 118–131.
278.
KeallP.J., KiniV.R., VedamS.S., and MohanR. (2001). ‘Motion adaptive x-ray therapy: A feasibility study,’ Phys. Med. Biol.46, 1–10.
279.
KeallP.J., SiebersJ.V., JoshiS., and MohanR. (2004). ‘Monte Carlo as a four-dimensional radiotherapy treatment-planning tool to account for respiratory motion,’ Phys. Med. Biol.49, 3639–3648.
280.
KellererA.M., and RossiH.H. (1974). ‘The theory of dual radiation action,’ Curr. Top. Radiat. Res. Q.85–158.
281.
KimJ., ParkY.K., SharpG., BusseP., and WineyB. (2017). ‘Water equivalent path length calculations using scatter-corrected head and neck CBCT images to evaluate patients for adaptive proton therapy,’ Phys. Med. Biol.62, 59–72.
282.
KirkpatrickJ.P., van der KogelA.J., and SchultheissT.E. (2010). ‘Radiation dose-volume effects in the spinal cord,’ Int. J. Radiat. Oncol. Biol. Phys.76, S42–S49.
283.
KitagawaA., YamadaS., KohnoT., MurakamiT., MuramatsuM., NodaK., OgawaH., SatoY., YamadaT., YoshizawaJ., FuS., SekiguchiM., OhshiroY., HattoriT., ShibuyaS., MatsushitaH., SawadaK., and MorishitaO. (1994). ‘Development of the National Institute of Radiological Sciences electron-cyclotron-resonance ion-source for the heavy-ion medical accelerator in Chiba,’ Rev. Sci. Instrum.65, 1087–1089.
284.
KleinE.E., HanleyJ., BayouthJ., YinF.F., SimonW., DresserS., SeragoC., AguirreF., MaL., and ArjomandyB. (2009). ‘AAPM Task Group 142 report: Quality assurance of medical accelerators,’ Med. Phys.36, 4197–4212.
285.
KohnoR., KanematsuN., YusaK., and KanaiT. (2004). ‘Experimental evaluation of analytical penumbra calculation model for wobbled beams,’ Med. Phys.31, 1153–1157.
286.
KohnoR., NishioT., MiyagishiT., HiranoE., HottaK., KawashimaM., and OginoT. (2006). ‘Experimental evaluation of a MOSFET dosimeter for proton dose measurements,’ Phys. Med. Biol.51, 6077–6086.
287.
KonertT., VogelW., MacManusM.P., NestleU., BelderbosJ., GregoireV., ThorwarthD., FidarovaE., PaezD., ChitiA., and HannaG.G. (2015). ‘PET/CT imaging for target volume delineation in curative intent radiotherapy of non-small cell lung cancer: IAEA consensus report 2014,’ Radiother. Oncol.116, 27–34.
KosakiK., EckerS., HabermehlD., RiekenS., JäkelO., HerfarthK., DebusJ., CombsS. (2012). ‘Comparison of intensity modulated radiotherapy (IMRT) with intensity modulated particle therapy (IMPT) using fixed beams or an ion gantry for the treatment of patients with skull base meningiomas,’ Radiat. Oncol.7, 44.
290.
KoschikA., OsmićF., UrschützP., and BenediktM. (2014). ‘Status of MedAustron, the Austrian Ion Therapy and Research Centre,’ pp. 2146–2148 in Proc. IPAC’14: 5th International Particle Accelerator Conference, http://cds.cern.ch/record/2003152/files/wepro081.pdf (December 20 2018, date last accessed) (European Organization for Nuclear Research, Geneva).
291.
KotoM., MiyamotoT., YamamotoN., NishimuraH., YamadaS., and TsujiiH. (2004). ‘Local control and recurrence of stage I non-small cell lung cancer after carbon ion radiotherapy,’ Radiother. Oncol.71, 147–156.
292.
KrämerM. (2001). ‘Treatment planning for heavy-ion radiotherapy: Biological optimization of multiple beam ports,’ J. Radiat. Res.42, 39–46.
293.
KrämerM., and JäkelO. (2005). ‘Biological dose optimization using ramp-like dose gradients in ion irradiation fields,’ Phys. Med.21, 107–111.
294.
KrämerM., and ScholzM. (2000). ‘Treatment planning for heavy-ion radiotherapy: Calculation and optimization of biologically effective dose,’ Phys. Med. Biol.45, 3319–3330.
295.
KrämerM., and ScholzM. (2006). ‘Rapid calculation of biological effects in ion radiotherapy,’ Phys. Med. Biol.51, 1959–1970.
296.
KrämerM., JäkelO., HabererT., KraftG., SchardtD., and WeberU. (2000). ‘Treatment planning for heavy-ion radiotherapy: Physical beam model and dose optimization,’ Phys. Med. Biol.45, 3299–3317.
297.
KreßJ., MinoharaS., EndoM., DebusJ., and KanaiT. (1999). ‘Patient position verification using CT images,’ Med. Phys.26, 941–948.
298.
KumazakiY., AkagiT., YabouT., SugaD., HishikawaY., and TeshimaT. (2007). ‘Determination of the mean excitation energy ofwater from proton beam ranges,’ Radiat. Meas.42, 1683–1691.
299.
KurosawaT., NakaoN., NakamuraT., UwaminoY., ShibataT., NakanishiN., FukumuraA., and MurakamiK. (1999). ‘Measurements of secondary neutrons produced from thick targets bombarded by high-energy helium and carbon ions,’ Nucl. Sci. Eng.132, 30–57.
300.
KurzC., NijhuisR., ReinerM., GanswindtU., ThiekeC., BelkaC., ParodiK., and LandryG. (2016a). ‘Feasibility of automated proton therapy plan adaptation for head and neck tumors using cone beam CT images,’ Radiat. Oncol.11, 64.
301.
KurzC., KampF., ParkY.K., ZollnerC., RitS., HansenD., PodestaM., SharpG.C., LiM., ReinerM., HofmaierJ., NepplS., ThiekeC., NijhuisR., GanswindtU., BelkaC., WineyB.A., ParodiK., and LandryG. (2016b). ‘Investigating deformable image registration and scatter correction for CBCT-based dose calculation in adaptive IMPT,’ Med. Phys.43, 5635.
302.
KurzC., BauerJ., UnholtzD., RichterD., HerfarthK., DebusJ., and ParodiK. (2016c). ‘Initial clinical evaluation of PET-based ion beam therapy monitoring under consideration of organ motion,’ Med. Phys.43, 975–982.
303.
KusanoY., KanaiT., KaseY., MatsufujiN., KomoriM., KanematsuN., ItoA., and UchidaH. (2007a). ‘Dose contributions from large-angle scattered particles in therapeutic carbon beams,’ Med. Phys.34, 193–198.
304.
KusanoY., KanaiT., YonaiS., KomoriM., IkedaN., TachikawaY., ItoA., and UchidaH. (2007b). ‘Field-size dependence of doses of therapeutic carbon beams,’ Med. Phys.34, 4016–4022.
305.
Kutsutani-NakamuraY. (1978). ‘Treatment planning method in the use of the TDF biological equivalent concept in fast neutron therapy,’ Nihon Igaku Houshasen Gakkai Zasshi38, 950–960.
306.
LandryG., NijhuisR., DedesG., HandrackJ., ThiekeC., JanssensG., Orban de XivryJ., ReinerM., KampF., WilkensJ.J., PaganelliC., RiboldiM., BaroniG., GanswindtU., BelkaC., and ParodiK. (2015). ‘Investigating CT to CBCT image registration for head and neck proton therapy as a tool for daily dose recalculation,’ Med. Phys.42, 1354–1366.
307.
LangenK.M., and JonesD.T. (2001). ‘Organ motion and its management,’ Int. J. Radiat. Oncol. Biol. Phys.50, 265–278.
308.
LangmanG., PatelA., and BowleyD.M. (2015). ‘Size and distribution of lymph nodes in rectal cancer resection specimens,’ Dis. Colon Rectum58, 406–414.
309.
LarssonB. (1961). ‘Pre-therapeutic physical experiments with high energy protons,’ Br. J. Radiol.34, 143–151.
310.
LarssonB. (1967). ‘Radiological properties of beams of high-energy protons,’ Radiat. Res.7, 304–311.
311.
LattanziJ., McNeelyS., HanlonA., DasI., SchultheissT.E., and HanksG.E. (1998). ‘Daily CT localization for correcting portal errors in the treatment of prostate cancer,’ Int. J. Radiat. Oncol. Biol. Phys.41, 1079–1086.
312.
LattanziJ., McNeeleyS., PinoverW., HorwitzE., DasI., SchultheissT.E., and HanksG.E. (1999). ‘A comparison of daily CT localization to a daily ultrasound-based system in prostate cancer,’ Int. J. Radiat. Oncol. Biol. Phys.43, 719–725.
313.
LawrenceJ.H. (1957). ‘Proton irradiation of the pituitary,’ Cancer10, 795–798.
314.
LeerJ.W., CorverR., KrausJ.J., vd TogtJ.C., and BurumaO.J. (1995). ‘A quality assurance system based on ISO standards: experience in a radiotherapy department,’ Radiother. Oncol.35, 75–81.
315.
LeksellL. (1951). ‘The stereotaxic method and radiosurgery of the brain,’ Acta Chir. Scand.102, 316–319.
316.
LetourneauD., WongR., MoseleyD., SharpeM.B., AnsellS., GospodarowiczM., and JaffrayD.A. (2007). ‘Online planning and delivery technique for radiotherapy of spinal metastases using cone-beam CT: image quality and system performance,’ Int. J. Radiat. Oncol. Biol. Phys.67, 1229–1237.
317.
LevyR.P., BlakelyE.A., ChuW.T., CoutrakonG.B., HugE.B., KraftG., TsujiiH., McDanielF.D., and DoyleB.L. (2009). ‘The current status and future directions of heavy charged particle therapy in medicine,’ pp. 410 to 425 in Application of Accelerators in Research and Industry: Twentieth International Conference, Vol. 1099 (American Institute of Physics, College Park, Maryland).
318.
LiQ., and SihverL. (2011). ‘Therapeutic techniques applied in the heavy-ion therapy at IMP,’ Nucl. Instrum. Methods Phys. Res. B269, 664–670.
319.
LiQ.A., DaiZ.Y., YanZ., JinX.D., LiuX.G., and XiaoG.Q. (2007). ‘Heavy-ion conformal irradiation in the shallow-seated tumor therapy terminal at HIRFL,’ Med. Biol. Eng. Comput.45, 1037–1043.
320.
LiamsuwanT., HultqvistM., LindborgL., UeharaS., and NikjooH. (2014). ‘Microdosimetry of proton and carbon ions,’ Med. Phys.41, 081721. doi:10.1118/1.4888338.
321.
Lillis-HearneP.K., and CastroJ.R. (1995). ‘Indications for heavy ions-lessons from Berkeley,’ pp. 133–141 in Ion Beams in Tumour Therapy, Linz, U., Ed. (Chapman & Hall, London).
322.
LimK., SmallW.Jr., PortelanceL., CreutzbergC., Jurgenliemk-SchulzI.M., MundtA., MellL.K., MayrN., ViswanathanA., JhingranA., EricksonB., De los SantosJ., GaffneyD., YasharC., BeriwalS., WolfsonA., TaylorA., BoschW., El NaqaI., FylesA., and GynI.C. (2011). ‘Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy for the definitive treatment of cervix cancer,’ Int. J. Radiat. Oncol. Biol. Phys.79, 348–355.
323.
LinL., SourisK., KangM., GlickA., LinH., HuangS., StutzerK., JanssensG., SterpinE., LeeJ.A., SolbergT.D., McDonoughJ.E., SimoneC.B.II, and Ben-JosefE. (2017). ‘Evaluation of motion mitigation using abdominal compression in the clinical implementation of pencil beam scanning proton therapy of liver tumors,’ Med. Phys.44, 703–712.
324.
LingC.C., HummJ., LarsonS., AmolsH., FuksZ., LeibelS., and KoutcherJ.A. (2000). ‘Towards multidimensional radiotherapy (MD-CRT): Biological imaging and biological conformality,’ Int. J. Radiat. Oncol. Biol. Phys.47, 551–560.
325.
LinstadtD.E., CastroJ.R., and PhillipsT.L. (1991). ‘Neon ion radiotherapy: results of the phase I/II clinical trial,’ Int. J. Radiat. Oncol. Biol. Phys.20, 761–769.
326.
LinzU. (2011). Ion Beam Therapy: Fundamentals, Technology, Clinical Applications (Springer Science & Business Media, Berlin).
327.
LitovchenkoP.G., BarabashL.I., RosenfeldA.B., KhivrichV.I., ZinetsO.S., KutsV.I., MarusanI.A., PetrovV.I., SluchenkovG.F., KovalG.N., FominychV.I., BelovodskiyL.F., DumikA.I., and KiblikV.Y. (1990). ‘MOS structure for emergency-gamma and proton dosimetry,’ Radiat. Prot. Dosimetry33, 179–182.
328.
LiuH.H., BalterP., TuttT., ChoiB., ZhangJ., WangC., ChiM., LuoD.S., PanT.S., HunjanS., StarkschallG., RosenI., PradoK., LiaoZ.X., ChangJ., KomakiR., CoxJ.D., MohanR., and DongL. (2007). ‘Assessing respiration-induced tumor motion and internal target volume using four-dimensional computed tomography for radiotherapy of lung cancer,’ Int. J. Radiat. Oncol. Biol. Phys.68, 531–540.
329.
LivingstonM.S. (1931). The Production of High Velocity Hydrogen Ions Without the Use of High Voltages, Ph.D. thesis (University of California, Berkeley).
330.
LlacerJ. (1988). ‘Positron emission medical measurements with accelerated radioactive ion beams,’ Nucl. Sci. Appl.3, 111–131.
331.
LlacerJ., TobiasC.A., HolleyW.R., and KanaiT. (1984). ‘On-line characterization of heavy-ion beams with semiconductor detectors,’ Med. Phys.11, 266–278.
332.
LomaxA.J. (2008a). ‘Intensity modulated proton therapy and its sensitivity to treatment uncertainties 1: the potential effects of calculational uncertainties,’ Phys. Med. Biol.53, 1027–1042.
333.
LomaxA.J. (2008b). ‘Intensity modulated proton therapy and its sensitivity to treatment uncertainties 2: the potential effects of inter-fraction and inter-field motions,’ Phys. Med. Biol.53, 1043–1056.
334.
LomaxA.J., BohringerT., BolsiA., CorayD., EmertF., GoiteinG., JermannM., LinS., PedroniE., RutzH., StadelmannO., TimmermannB., VerweyJ., and WeberD.C. (2004). ‘Treatment planning and verification of proton therapy using spot scanning: initial experiences,’ Med. Phys.31, 3150–3157.
335.
LorenzoC., AndreaP., BarbaraV., DenisP., RosariaF.M., PieroF., VivianaV., AlbertoI., MarioC., BrugnatelliS., TommasoD., BugadaD., MarcelloM., MarioA., FrancescaV., RobertoO., and PaoloD. (2016). ‘Surgical spacer placement prior carbon ion radiotherapy (CIRT): an effective feasible strategy to improve the treatment for sacral chordoma,’ World J. Surg. Oncol.14, 211.
336.
LourencoA., ThomasR., HomerM., BouchardH., RossommeS., RenaudJ., KanaiT., RoyleG., and PalmansH. (2017). ‘Fluence correction factor for graphite calorimetry in a clinical high-energy carbon-ion beam,’ Phys. Med. Biol.62, N134.
337.
LowD. (2011). ‘4D imaging and 4D radiation therapy: a new era of therapy design and delivery,’ Front. Radiat. Ther. Oncol.43, 99–117.
338.
LudewigtB.A., ChuW.T., PhillipsM.H., and RennerT.R. (1991). ‘Accelerated helium-ion beams for radiotherapy and stereotactic radiosurgery,’ Med. Phys.18, 36–42.
339.
LührA., HansenD.C., JakelO., SobolevskyN., and BasslerN. (2011a). ‘Analytical expressions for water-to-air stopping-power ratios relevant for accurate dosimetry in particle therapy,’ Phys. Med. Biol.56, 2515–2533.
340.
LührA., HansenD.C., SobolevskyN., PalmansH., RossommeS., and BasslerN. (2011b). ‘Fluence correction factors and stopping power ratios for clinical ion beams,’ Acta Oncol.50, 797–805.
341.
LymanJ.T. (1985). ‘Complication probability as assessed from dose volume histograms,’ Radiat. Res.104, S13–S19.
342.
LymanJ.T., and HowardJ. (1977). ‘Dosimetry and instrumentation for helium and heavy ions,’ Int. J. Radiat. Oncol. Biol. Phys.3, 81–85.
343.
LymanJ.T., and WolbarstA.B. (1987). ‘Optimization of radiation therapy, III: a method of assessing complication probabilities from dose-volume histograms,’ Int. J. Radiat. Oncol. Biol. Phys.13, 103–109.
344.
LymanJ.T., HowardJ., KansteinL., and AlonsoJ.R. (1980). ‘Radiological physics of heavy charged-particle beams used for therapy,’ pp. 319 to 324 in Biological and Medical Research with Accelerated Heavy Ions at the Bevalac, 1977–1980, Pirruccello, M.C. and Tobias, C.A., Eds., LBL-11220 (Lawrence Berkeley Laboratory, Berkeley, California).
345.
MagrinG., and MayerR. (2015). ‘Microdosimetry in ion-beam therapy,’ Mod. Phys. Lett. A30, 1540027.
346.
MairaniA., BronsS., CeruttiF., FassoA., FerrariA., KramerM., ParodiK., ScholzM., and SommererF. (2010). ‘The FLUKA Monte Carlo code coupled with the local effect model for biological calculations in carbon ion therapy,’ Phys. Med. Biol.55, 4273–4289.
347.
MartisikovaM., and JäkelO. (2010). ‘Dosimetric properties of Gafchromic EBT films in monoenergetic medical ion beams,’ Phys. Med. Biol.55, 3741–3751.
348.
MartisikovaM., HesseB., NairzO., and JäkelO. (2009). Performance of a flatpanel Detector in Scanned Ion Beams (German Medical Science GMS Publishing House, Düsseldorf).
349.
MartisikovaM., HesseB.M., NairzO., and JäkelO. (2011). ‘Test of an amorphous silicon detector in medical proton beams,’ Nucl. Instrum. Methods Phys. Res. A633, s259–s261.
350.
MartisikovaM., HartmannB., HesseB.M., BronsS., AckermannB., and JäkelO. (2012). ‘Characterization of a flat-panel detector for ion beam spot measurements,’ Phys. Med. Biol.57, 485–497.
351.
MartisikovaM., BronsS., HesseB.M., and JäkelO. (2013). ‘High-resolution fluence verification for treatment plan specific QA in ion beam radiotherapy,’ Phys. Med. Biol.58, 1725–1738.
352.
MatsufujiN., TomuraH., FutamiY., YamashitaH., HigashiA., MinoharaS., EndoM., and KanaiT. (1998). ‘Relationship between CT number and electron density, scatter angle and nuclear reaction for hadron-therapy treatment planning,’ Phys. Med. Biol.43, 3261–3275.
353.
MatsufujiN., FukumuraA., KomoriM., KanaiT., and KohnoT. (2003). ‘Influence of fragment reaction of relativistic heavy charged particles on heavy-ion radiotherapy,’ Phys. Med. Biol.48, 1605–1623.
354.
MatsufujiN., KomoriM., SasakiH., AkiuK., OgawaM., FukumuraA., UrakabeE., InaniwaT., NishioT., KohnoT., and KanaiT. (2005). ‘Spatial fragment distribution from a therapeutic pencil-like carbon beam in water,’ Phys. Med. Biol.50, 3393–3403.
355.
MatsufujiN., KanaiT., KanematsuN., MiyamotoT., BabaM., KamadaT., KatoH., YamadaS., MizoeJ.E., and TsujiiH. (2007). ‘Specification of carbon ion dose at the National Institute of Radiological Sciences (NIRS),’ J. Radiat. Res.48, A81–A86.
356.
McCaslinJ.B., LaPlantP.R., SmithA.R., SwansonW.P., and ThomasR.H. (1985). ‘Neutron production by Ne and Si ions on a thick Cu target at 670 MeV a with application to radiation protection,’ IEEE Trans. Nucl. Sci.32, 3104–3106.
357.
McEwenM., DeWerdL., IbbottG., FollowillD., RogersD.W., SeltzerS., and SeuntjensJ. (2014). ‘Addendum to the AAPM's TG‐51 protocol for clinical reference dosimetry of high‐energy photon beams,’ Med. Phys.41 041501-1–041501-20.
358.
McGowanS.E., BurnetN.G., and LomaxA.J. (2013). ‘Treatment planning optimisation in proton therapy,’ Br. J. Radiol.86, 20120288.
359.
McGowanS.E., AlbertiniF., ThomasS.J., and LomaxA.J. (2015). ‘Defining robustness protocols: a method to include and evaluate robustness in clinical plans,’ Phys. Med. Biol.60, 2671–2684.
360.
MedinJ., and AndreoP. (1997). ‘Monte Carlo calculated stopping-power ratios, water/air, for clinical proton dosimetry (50–250 MeV),’ Phys. Med. Biol.42, 89–105.
361.
MeierG., BessonR., NanzA., SafaiS., and LomaxA.J. (2015). ‘Independent dose calculations for commissioning, quality assurance and dose reconstruction of PBS proton therapy,’ Phys. Med. Biol.60, 2819–2836.
362.
MeschiniG., SeregniM., PellaA., CioccaM., FossatiP., ValvoF., RiboldiM., and BaroniG. (2017). ‘Evaluation of residual abdominal tumour motion in carbon ion gated treatments through respiratory motion modelling,’ Phys. Med.34, 28–37.
363.
MillerD.W., BlochP.H., CunninghamJ.R., CurranB.H., IbbottG.S., JonesD., JuciusS.Z., LeavittD.D., MohanR., and van de GeijinJ. (1995). Radiation Treatment Planning Dosimetry Verification, AAPM Report No. 55 (American Association of Physicists in Medicine, College Park, Maryland).
364.
MinoharaS., KanaiT., EndoM., NodaK., and KanazawaM. (2000). ‘Respiratory gated irradiation system for heavy-ion radiotherapy,’ Int. J. Radiat. Oncol. Biol. Phys.47, 1097–1103.
365.
MirandolaA., MolinelliS., FreixasG.V., MairaniA., GallioE., PanizzaD., RussoS., CioccaM., DonettiM., MagroG., GiordanengoS., and OrecchiaR. (2015). ‘Dosimetric commissioning and quality assurance of scanned ion beams at the Italian National Center for Oncological Hadrontherapy,’ Med. Phys.42, 5287–5300.
366.
MizushimaK., KatagiriK., IwataY., FurukawaT., FujimotoT., SatoS., HaraY., ShiraiT., and NodaK. (2014). ‘Experimental studies of systematic multiple-energy operation at HIMAC synchrotron,’ Nucl. Instrum. Methods Phys. Res. B331, 243–247.
367.
MöhlerC., WohlfahrtP., RichterC., and GreilichS. (2016). ‘Range prediction for tissue mixtures based on dual-energy CT,’ Phys. Med. Biol.61, N268–N275.
368.
MolinelliS., MagroG., MairaniA., MatsufujiN., KanematsuN., InaniwaT., MirandolaA., RussoS., MastellaE., HasegawaA., TsujiH., YamadaS., VischioniB., VitoloV., FerrariA., CioccaM., KamadaT., TsujiiH., OrecchiaR., and FossatiP. (2016). ‘Dose prescription in carbon ion radiotherapy: how to compare two different RBE-weighted dose calculation systems,’ Radiother. Oncol.120, 307–312.
369.
MoriS. (2014). ‘Real-time image-processing algorithm for markerless tumour tracking using x-ray fluoroscopic imaging,’ Br. J. Radiol.87, 20140001.
370.
MoriS., and ChenG.T.Y. (2008). ‘Quantification and visualization of charged particle range variations,’ Int. J. Radiat. Oncol. Biol. Phys.72, 268–277.
371.
MoriS., ChenG.T., and EndoM. (2007). ‘Effects of intrafractional motion on water equivalent pathlength in respiratory-gated heavy charged particle beam radiotherapy,’ Int. J. Radiat. Oncol. Biol. Phys.69, 308–317.
372.
MoriS., AsakuraH., KandatsuS., KumagaiM., BabaM., and EndoM. (2008). ‘Magnitude of residual internal anatomy motion on heavy charged particle dose distribution in respiratory gated lung therapy,’ Int. J. Radiat. Oncol. Biol. Phys.71, 587–594.
373.
MoriS., KanematsuN., AsakuraH., SharpG.C., KumagaiM., DobashiS., NakajimaM., YamamotoN., KandatsuS., and BabaM. (2011). ‘Four-dimensional lung treatment planning in layer-stacking carbon ion beam treatment: comparison of layer-stacking and conventional ungated/gated irradiation,’ Int. J. Radiat. Oncol. Biol. Phys.80, 597–607.
374.
MoriS., ShibayamaK., TanimotoK., KumagaiM., MatsuzakiY., FurukawaT., InaniwaT., ShiraiT., NodaK., TsujiH., and KamadaT. (2012). ‘First clinical experience in carbon ion scanning beam therapy: retrospective analysis of patient positional accuracy,’ J. Radiat. Res.53, 760–768.
375.
MoriS., ZenklusenS., and KnopfA.C. (2013). ‘Current status and future prospects of multi-dimensional image-guided particle therapy,’ Radiol. Phys. Technol.6, 249–272.
376.
MoriS., InaniwaT., MikiK., ShiraiT., and NodaK. (2014a). ‘Implementation of a target volume design function for intrafractional range variation in a particle beam treatment planning system,’ Br. J. Radiol.87, 20140233.
377.
MoriS., InaniwaT., FurukawaT., TakahashiW., NakajimaM., ShiraiT., NodaK., YasudaS., and YamamotoN. (2014b). ‘Amplitude-based gated phase-controlled rescanning in carbon-ion scanning beam treatment planning under irregular breathing conditions using lung and liver 4DCTs,’ J. Radiat. Res.55, 948–958.
378.
MoriS., KumagaiM., MikiK., FukuharaR., and HaneishiH. (2015). ‘Development of fast patient position verification software using 2D–3D image registration and its clinical experience,’ J. Radiat. Res.56, 818–829.
379.
MoriS., KarubeM., ShiraiT., TajiriM., TakekoshiT., MikiK., ShiraishiY., TanimotoK., ShibayamaK., YasudaS., YamamotoN., YamadaS., TsujiH., NodaK., and KamadaT. (2016). ‘Carbon-ion pencil beam scanning treatment with gated markerless tumor tracking: an analysis of positional accuracy,’ Int. J. Radiat. Oncol. Biol. Phys.95, 258–266.
380.
MoyersM.F., and LesynaW. (2004). ‘Isocenter characteristics of an external ring proton gantry,’ Int. J. Radiat. Oncol. Biol. Phys.60, 1622–1630.
381.
MurakamiM., DemizuY., NiwaY., MiyawakiD., TerashimaK., ArimuraT., MimaM., NagayamaS., MaedaT., and BabaM. (2009). Current Status of the HIBMC and Results of Representative Diseases, Vol. 1153 (American Institute of Physics, College Park, Maryland).
382.
MuramatsuM., KitagawaA., SakamotoY., SatoS., SatoY., OgawaH., YamadaS., OgawaH., YoshidaY., and DrentjeA.G. (2005). ‘Development of a compact electron-cyclotron-resonance ion source for high-energy carbon-ion therapy,’ Rev. Sci. Instrum.76, 113304.
383.
NaganoA., MinoharaS., KatoS., KiyoharaH., and AndoK. (2012). ‘Adaptive radiotherapy based on the daily regression of a tumor in carbon-ion beam irradiation,’ Phys. Med. Biol.57, 8343–8356.
384.
NairzO., WinterM., HeegP., and JäkelO. (2013). ‘Accuracy of robotic patient positioners used in ion beam therapy,’ Radiat. Oncol.8, 124.
385.
NegoroY., NagataY., AokiT., MizowakiT., ArakiN., TakayamaK., KokuboM., YanoS., KogaS., SasaiK., ShibamotoY., and HiraokaM. (2001). ‘The effectiveness of an immobilization device in conformal radiotherapy for lung tumor: Reduction of respiratory tumor movement and evaluation of the daily setup accuracy,’ Int. J. Radiat. Oncol. Biol. Phys.50, 889–898.
386.
NehmehS.A., ErdiY.E., RosenzweigK.E., SchoderH., LarsonS.M., SquireO.D., and HummJ.L. (2003). ‘Reduction of respiratory motion artifacts in PET imaging of lung cancer by respiratory correlated dynamic PET: methodology and comparison with respiratory gated PET,’ J. Nucl. Med.44, 1644–1648.
387.
NewhauserW.D., RechnerL., MirkovicD., YepesP., KochN.C., TittU., FontenotJ.D., and ZhangR. (2013). ‘Benchmark measurements and simulations of dose perturbations due to metallic spheres in proton beams,’ Radiat. Meas.58, 37–44.
388.
NiebuhrN.I., JohnenW., GüldaglarT., RunzA., EchnerG., MannP., MöhlerC., PfaffenbergerA., JäkelO., and GreilichS. (2016). ‘Technical note: radiological properties of tissue surrogates used in a multimodality deformable pelvic phantom for MR‐guided radiotherapy,’ Med. Phys.43, 908–916.
389.
NiemierkoA. (1997). ‘Reporting and analyzing dose distributions: a concept of equivalent uniform dose,’ Med. Phys.24, 103–110.
390.
NiitaK., SatoT., IwaseH., NoseH., NakashimaH., and SihverL. (2006). ‘PHITS – a particle and heavy ion transport code system,’ Radiat. Meas.41, 1080–1090.
391.
NischwitzS.P., BauerJ., WelzelT., RiefH., JäkelO., HabererT., FreyK., DebusJ., ParodiK., CombsS.E., and RiekenS. (2015). ‘Clinical implementation and range evaluation of in vivo PET dosimetry for particle irradiation in patients with primary glioma,’ Radiother. Oncol.115, 179–185.
392.
NodaK. (2016). ‘Development of C-ion radiotherapy technologies in Japan,’ pp. 37–57 in Particle Radiotherapy: Emerging Technology for Treatment of Cancer, Rath, A.K., and Sahoo, N., Eds. (Springer India, New Delhi).
393.
NodaK., KanazawaM., ItanoA., TakadaE., TorikoshiM., ArakiN., YoshizawaJ., SatoK., YamadaS., OgawaH., ItohH., NodaA., TomizawaM., and YoshizawaM. (1996). ‘Slow beam extraction by a transverse RF field with AM and FM,’ Nucl. Instrum. Methods Phys. Res. A374, 269–277.
394.
NodaA., HojoS., KatagiriK., NakaoM., NodaE., NodaK., SugiuraA., SuzukiK., WakuiT., and GrieserM. (2015). ‘Acceleration scheme of radioactive ion beam with HIMAC and its injector linac,’ pp. 197–199 in Proc. HIAT2015: Proc. 13th International Conference on Heavy Ion Accelerator Technology, http://accelconf.web.cern.ch/AccelConf/HIAT2015/papers/wepb03.pdf (December 20 2018, date last accessed) (European Organization for Nuclear Research, Geneva).
395.
NodaK., FurukawaT., FujimotoT., InaniwaT., IwataY., KanaiT., KanazawaM., MinoharaS., MiyoshiT., MurakamiT., SanoY., SatoS., TakadaE., TakeiY., TorikaiK., and TorikoshiM. (2008). ‘New treatment facility for heavy-ion cancer therapy at HIMAC,’ Nucl. Instrum. Methods Phys. Res. B266, 2182–2185.
396.
NomiyaT., TsujiH., HirasawaN., KatoH., KamadaT., MizoeJ., KishiH., KamuraK., WadaH., NemotoK., and TsujiiH. (2008). ‘Carbon ion radiation therapy for primary renal cell carcinoma: initial clinical experience,’ Int. J. Radiat. Oncol. Biol. Phys.72, 828–833.
397.
OffersenB.V., BoersmaL.J., KirkoveC., HolS., AznarM.C., SolaA.B., KirovaY.M., PignolJ.P., RemouchampsV., VerhoevenK., WeltensC., ArenasM., GabrysD., KopekN., KrauseM., LundstedtD., MarinkoT., MonteroA., YarnoldJ., and PoortmansP. (2016). ‘ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer, version 1.1,’ Radiother. Oncol.118, 205–208.
398.
OhnoT., KanaiT., YamadaS., YusaK., TashiroM., ShimadaH., TorikaiK., YoshidaY., KitadaY., KatohH., IshiiT., and NakanoT. (2011). ‘Carbon ion radiotherapy at the Gunma University Heavy Ion Medical Center: new facility set-up’ Cancers3, 4046–4060.
399.
OrecchiaR., KrengliM., Jereczek-FossaB.A., FranzettiS., and GerardJ.P. (2004). ‘Clinical and research validity of hadrontherapy with ion beams,’ Crit. Rev. Oncol. Hematol.51, 81–90.
400.
OrecchiaR., RossiS., FossatiP., McDanielF.D., and DoyleB.L. (2009a). ‘Indications of carbon ion therapy at CNAO,’ pp. 399 to 404 in AIP Conference Proceedings (American Institute of Physics, College Park, Maryland).
401.
OrecchiaR., FossatiP., and RossiS. (2009b). ‘The national center for oncological hadron therapy: status of the project and future clinical use of the facility,’ Tumori95, 169–176.
402.
Osinga-BlättermannJ., BronsS., GreilichS., JäkelO., and KraussA. (2017). ‘Direct determination of k Q for farmer-type ionization chambers in a clinical scanned carbon ion beam using water calorimetry,’ Phys. Med. Biol.62, 2033.
403.
OsmićF., KoschikA., UrschützP., and BenediktM. (2014) “Status of MedAustron, the Austrian Ion Therapy and Research Centre,” pp. 2146 to 2148 in Proceedings of the 5th International Particle Accelerator Conference (IPAC’14), http://cds.cern.ch/record/2003152/files/wepro081.pdf (accessed April 15, 2019) (CERN, Geneva).
404.
O'SullivanB., WunderJ., and PistersP. (2004). ‘Target description for radiotherapy of soft tissue sarcoma,’ pp. 205–227 in Clinical Target Volumes in Conformal and Intensity Modulated Radiation Therapy – A Clinical Guide to Cancer Treatement, Grégoire, V, Scalliet, K., and Ang, K., Eds. (Springer, Berlin).
405.
PaganettiH. (2002). ‘Nuclear interactions in proton therapy: dose and relative biological effect distributions originating from primary and secondary particles,’ Phys. Med. Biol.47, 747–764.
406.
PalmansH. (2006). ‘Perturbation factors for cylindrical ionization chambers in proton beams. Part I: corrections for gradients,’ Phys. Med. Biol.51, 3483–3501.
407.
PalmansH., and VerhaegenF. (2000). ‘On the effective point of measurement of cylindrical ionization chambers for proton beams and other heavy charged particle beams,’ Phys. Med. Biol.45, L20–L23.
408.
PalmansH., VerhaegenF., DenisJ.M., VynckierS., and ThierensH. (2001). ‘Experimental p(wall) and p(cel) correction factors for ionization chambers in low-energy clinical proton beams,’ Phys. Med. Biol.46, 1187–1204.
409.
PardoJ., DonettiM., BourhalebF., AnsarinejadA., AttiliA., CirioR., GarellaM.A., GiordanengoS., GivehchiN., La RosaA., MarchettoF., MonacoV., PeckaA., PeroniC., RussoG., and SacchiR. (2009). ‘Heuristic optimization of the scanning path of particle therapy beams,’ Med. Phys.36, 2043–2051.
410.
ParodiK. (2004). On the Feasibility of Dose Quantication with In-Beam PET Data in Radiotherapy with12C and Proton Beams, Ph.D. Thesis (Helmholtz Center, Dresden, Germany).
411.
ParodiK., and EnghardtW. (2000). ‘Potential application of PET in quality assurance of proton therapy,’ Phys. Med. Biol.45, N151–N156.
412.
ParodiK., EnghardtW., and HabererT. (2002). ‘In-beam PET measurements of beta+ radioactivity induced by proton beams,’ Phys. Med. Biol.47, 21–36.
413.
ParodiK., MairaniA., BronsS., NaumannJ., SommererF., and HabererT. (2009a). The Application of the FLUKA Monte Carlo Code to Basic Data Generation for Clinical Treatment Planning of Scanned Proton and Carbon Ion Therapy (Second European Workshop on Monte Carlo Treatment Planning. 2009., Cardiff, UK).
414.
ParodiK., SaitoN., ChaudhriN., RichterC., DuranteM., EnghardtW., RietzelE., and BertC. (2009b). ‘4D in-beam positron emission tomography for verification of motion-compensated ion beam therapy,’ Med. Phys.36, 4230–4243.
415.
ParodiK., MairaniA., BronsS., HaschB.G., SommererF., NaumannJ., JäkelO., HabererT., and DebusJ. (2012). ‘Monte Carlo simulations to support start-up and treatment planning of scanned proton and carbon ion therapy at a synchrotron-based facility,’ Phys. Med. Biol.57, 3759–3784.
416.
PartinA.W., MangoldL.A., LammD.M., WalshP.C., EpsteinJ.I., and PearsonJ.D. (2001). ‘Contemporary update of prostate cancer staging nomograms (partin tables) for the new millennium,’ Urology58, 843–848.
417.
PaulH. (2003). Stopping Power of Matter for Ions: Graphs, Data, Comments and Programs [online] MSTAR Ver. 3, https://www-nds.iaea.org/stopping/ (July 18 2018, date last accessed) (International Atomic Energy Agency, Geneva).
418.
PaulH. (2006). ‘A comparison of recent stopping power tables for light and medium-heavy ions with experimental data, and applications to radiotherapy dosimetry,’ Nucl. Instrum. Methods Phys. Res. B247, 166–172.
419.
PaulH., GeithnerO., and JäkelO. (2007a). ‘The influence of stopping powers upon dosimetry for radiation therapy with energetic ions,’ Adv. Quantum Chem.52, 289–306.
420.
PaulH., GeithnerO., and JäkelO. (2007b). ‘The ratio of stopping powers of water and air for dosimetry applications in tumor therapy,’ Nucl. Instrum. Methods Phys. Res. B256, 561–564.
421.
PedroniE., BacherR., BlattmannH., BohringerT., CorayA., LomaxA., LinS., MunkelG., ScheibS., SchneiderU., and TourovskyA. (1995). ‘The 200-MeV proton therapy project at the Paul Scherrer Institute: conceptual design and practical realization,’ Med. Phys.22, 37–53.
422.
PedroniE., ScheibS., BohringerT., CorayA., GrossmannM., LinS., and LomaxA. (2005). ‘Experimental characterization and physical modelling of the dose distribution of scanned proton pencil beams,’ Phys. Med. Biol.50, 541–561.
423.
PellaA., RiboldiM., TagasteB., BianculliD., DesplanquesM., FontanaG., CerveriP., SeregniM., FattoriG., OrecchiaR., and BaroniG. (2014). ‘Commissioning and quality assurance of an integrated system for patient positioning and setup verification in particle therapy,’ Technol. Cancer Res. Treat.13, 303–314.
424.
PeroniM., SpadeaM.F., RiboldiM., FalconeS., VaccaroC., SharpG.C., and BaroniG. (2013). ‘Validation of automatic contour propagation for 4D treatment planning using multiple metrics,’ Technol. Cancer Res. Treat.12, 501–510.
425.
PetersA., CeeR., FeldmeierE., GalonskaM., HabererT., HöppnerK., ScheloskeS., SchoemersC., and WinkelmannT. (2012). ‘Five years of operation experience at HIT,’ pp. 1084 to 1086 in Proceedings of IPAC2012 (Institute of Electrical and Electronics Engineers, Piscataway, New Jersey).
PettiP.L., LymanJ.T., RennerT.R., CastroJ.R., CollierJ.M., DaftariI.K., and LudewigtB.A. (1991a). ‘Design of beam-modulating devices for charged-particle therapy,’ Med. Phys.18, 513–518.
428.
PettiP.L., LymanJ.T., and CastroJ.R. (1991b). ‘Sensitivity of helium beam-modulator design to uncertainties in biological data,’ Med. Phys.18, 506–512.
429.
PflugfelderD., WilkensJ.J., and OelfkeU. (2008). ‘Worst case optimization: A method to account for uncertainties in the optimization of intensity modulated proton therapy,’ Phys. Med. Biol.53, 1689–1700.
430.
PhillipsM.H., FrankelK.A., LymanJ.T., FabrikantJ.I., and LevyR.P. (1990). ‘Comparison of different radiation types and irradiation geometries in stereotactic radiosurgery,’ Int. J. Radiat. Oncol. Biol. Phys.18, 211–220.
431.
PhillipsM.H., PedroniE., BlattmannH., BoehringerT., CorayA., and ScheibS. (1992). ‘Effects of respiratory motion on dose uniformity with a charged particle scanning method,’ Phys. Med. Biol.37, 223–234.
432.
PintoM., De RydtM., DauvergneD., DedesG., FreudN., KrimmerJ., LetangJ.M., RayC., TestaE., and TestaM. (2015). ‘Technical note: Experimental carbon ion range verification in inhomogeneous phantoms using prompt gammas,’ Med. Phys.42, 2342–2346.
433.
PirruccelloM., and TobiasC.A. (1980). Biological and Medical Research with Accelerated Heavy Ions at the Bevalac, 1977–1980 (Lawrence BerkeleyLaboratory, University of California, Berkeley).
434.
PlathowC., ZimmermannH., FinkC., UmathumR., SchobingerM., HuberP., ZunaI., DebusJ., SchlegelW., MeinzerH.P., SemmlerW., KauczorH.U., and BockM. (2005). ‘Influence of different breathing maneuvers on internal and external organ motion: Use of fiducial markers in dynamic MRI,’ Int. J. Radiat. Oncol. Biol. Phys.62, 238–245.
435.
PönischF., ParodiK., HaschB.G., and EnghardtW. (2004). ‘The modelling of positron emitter production and PET imaging during carbon ion therapy,’ Phys. Med. Biol.49, 5217–5232.
PTCOG (2019). Particle Therapy Co-Operative Group. Facilities in Operation [online]. https://www.ptcog.ch/index.php/facilities-in-operation (October 23 2019, date last accessed) (Particle Therapy Co-Operative Group, Villigen, Switzerland).
439.
QinN., ShenC., TsaiM.Y., PintoM., TianZ., DedesG., PomposA., JiangS.B., ParodiK., and JiaX. (2018) ‘Full Monte Carlo-Based biologic treatment plan optimization system for intensity modulated carbon ion therapy on graphics processing unit,’ Int. J. Radiat. Oncol. Biol. Phys.100, 235–243.
440.
RajuM. (1995). ‘The history of ion beam therapy,’ pp. 3–9 in Ion Beams in Tumor Therapy, Linz, U., Ed. (Chapman & Hall, London).
441.
RennerT., ChuW., LudewigtB., HalliwellJ., NymanM., SinghR., StoverG., and StradtnerR. (1989). ‘Preliminary results of a raster scanning beam delivery system,’ pp. 672 to 674 in Proceedings of the 1989 IEEE Particle Accelerator Conference: Accelerator Science and Technology (Institute of Electrical and Electronics Engineers, New York).
442.
RiboldiM., OrecchiaR., and BaroniG. (2012). ‘Real-time tumour tracking in particle therapy: technological developments and future perspectives,’ Lancet Oncol.13, e383–e391.
443.
RichterD., GraeffC., JäkelO., CombsS.E., DuranteM., and BertC. (2014a). ‘Residual motion mitigation in scanned carbon ion beam therapy of liver tumors using enlarged pencil beam overlap,’ Radiother. Oncol.113, 290–295.
444.
RichterD., SaitoN., ChaudhriN., HartigM., EllerbrockM., JäkelO., CombsS.E., HabermehlD., HerfarthK., DuranteM., and BertC. (2014b). ‘Four-dimensional patient dose reconstruction for scanned ion beam therapy of moving liver tumors,’ Int. J. Radiat. Oncol. Biol. Phys.89, 175–181.
445.
RichterC., PauschG., BarczykS., PriegnitzM., KeitzI., ThieleJ., SmeetsJ., StappenF.V., BombelliL., FioriniC., HotoiuL., PeraliI., PrieelsD., EnghardtW., and BaumannM. (2016). ‘First clinical application of a prompt gamma based in vivo proton range verification system,’ Radiother. Oncol.118, 232–237.
446.
RietzelE., and BertC. (2010). ‘Respiratory motion management in particle therapy,’ Med. Phys.37, 449–460.
447.
RietzelE., PanT., and ChenG.T. (2005a). ‘Four-dimensional computed tomography: image formation and clinical protocol,’ Med. Phys.32, 874–889.
448.
RietzelE., ChenG.T., ChoiN.C., and WilletC.G. (2005b). ‘Four-dimensional image-based treatment planning: target volume segmentation and dose calculation in the presence of respiratory motion,’ Int. J. Radiat. Oncol. Biol. Phys.61, 1535–1550.
449.
RietzelE., LiuA.K., DoppkeK.P., WolfgangJ.A., ChenA.B., ChenG.T., and ChoiN.C. (2006). ‘Design of 4D treatment planning target volumes,’ Int. J. Radiat. Oncol. Biol. Phys.66, 287–295.
450.
RietzelE., SchardtD., and HabererT. (2007). ‘Range accuracy in carbon ion treatment planning based on CT-calibration with real tissue samples,’ Radiat. Oncol.2, 14.
451.
RingbækT.P., WeberU., PetersenJ.B., ThomsenB., and BasslerN. (2014). ‘Monte carlo simulations of new 2D ripple filters for particle therapy facilities,’ Acta Oncol.53, 40–49.
452.
RitchieC.J., HsiehJ., GardM.F., GodwinJ.D., KimY., and CrawfordC.R. (1994). ‘Predictive respiratory gating: A new method to reduce motion artifacts on CT scans,’ Radiology190, 847–852.
453.
RoelsS., DuthoyW., HaustermansK., PenninckxF., VandecaveyeV., BoterbergT., and De NeveW. (2006). ‘Definition and delineation of the clinical target volume for rectal cancer,’ Int. J. Radiat. Oncol. Biol. Phys.65, 1129–1142.
454.
RossiS. (2015). ‘The National Centre for Oncological Hadrontherapy (CNAO): status and perspectives,’ Phys. Med.31, 333–351.
455.
RossommeS., PalmansH., ThomasR., LeeN., DuaneS., BaileyM., ShipleyD., BertrandD., RomanoF., and CirroneP. (2013). ‘Reference dosimetry for light-ion beams based on graphite calorimetry,’ Radiat. Prot. Dosimetry161, 92–95.
456.
RossommeS., HopfgartnerJ., LeeN., DelorA., ThomasR., RomanoF., FukumuraA., VynckierS., and PalmansH. (2016). ‘Ion recombination correction in carbon ion beams,’ Med. Phys.43, 4198–4208.
457.
RucinskiA., BauerJ., CampbellP., BronsS., UnholtzD., HablG., HerfarthK., DebusJ., BertC., ParodiK., JäkelO., and HabererT. (2013). ‘Preclinical investigations towards the first spacer gel application in prostate cancer treatment during particle therapy at HIT,’ Radiat. Oncol.8, 134.
458.
RucinskiA., BronsS., RichterD., HablG., DebusJ., BertC., HabererT., and JäkelO. (2015). ‘Ion therapy of prostate cancer: daily rectal dose reduction by application of spacer gel,’ Radiat. Oncol.10, 56.
459.
SaagerM., GlowaC., PeschkeP., BronsS., GrunR., ScholzM., HuberP.E., DebusJ., and KargerC.P. (2016). ‘The relative biological effectiveness of carbon ion irradiations of the rat spinal cord increases linearly with LET up to 99 keV/μm,’ Acta Oncol.55, 1512–1515.
460.
SaitoN., BertC., ChaudhriN., GemmelA., SchardtD., DuranteM., and RietzelE. (2009). ‘Speed and accuracy of a beam tracking system for treatment of moving targets with scanned ion beams,’ Phys. Med. Biol.54, 4849–4862.
461.
SakamaM., KanaiT., KaseY., KomoriM., FukumuraA., and KohnoT. (2005). ‘Responses of a diamond detector to high-LET charged particles,’ Phys. Med. Biol.50, 2275–2289.
462.
SakamaM., KanaiT., and FukumuraA. (2008). ‘Development of a portable graphite calorimeter for radiation dosimetry,’ Igaku Butsuri28, 1–14.
463.
SakamaM., KanaiT., FukumuraA., and AbeK. (2009). ‘Evaluation of w values for carbon beams in air, using a graphite calorimeter,’ Phys. Med. Biol.54, 1111–1130.
464.
Sanchez-ParcerisaD., GemmelA., JäkelO., ParodiK., and RietzelE. (2012). ‘Experimental study of the water-to-air stopping power ratio of monoenergetic carbon ion beams for particle therapy,’ Phys. Med. Biol.57, 3629–3641.
465.
SatoT., KaseY., WatanabeR., NiitaK., and SihverL. (2009). ‘Biological dose estimation for charged-particle therapy using an improved PHITS code coupled with a microdosimetric kinetic model,’ Radiat. Res.171, 107–117.
466.
SchaffnerB., KanaiT., FutamiY., ShimboM., and UrakabeE. (2000). ‘Ridge filter design and optimization for the broad-beam three-dimensional irradiation system for heavy-ion radiotherapy,’ Med. Phys.27, 716–724.
ScheelerU., HabererTH, KrantzC., SieversS.T., StrohmeierM.M., CeeR., FeldmeierE., GalonskaM., HöppnerK., MosthafJ.M., PetersA., ScheloskeS., SchömersC., and WinkelmannT.W. (2016). “Recommissioning of the Marburg Ion-Beam Therapy Centre (MIT) Accelerator Facility,” pages 1908 to 1910 in Proceedings of the 7th International Particle Accelerator Conference (IPAC'16), http://jacow.org/ipac2016/papers/tupoy004.pdf (accessed April 15, 2019) (CERN, Geneva).
469.
SchlaeferA., FisselerJ., DieterichS., ShiomiH., ClearyK., and SchweikardA. (2005). ‘Feasibility of four-dimensional conformal planning for robotic radiosurgery,’ Med. Phys.32, 3786–3792.
470.
SchlegelW., PastyrO., BortfeldT., BeckerG., SchadL., GademannG., and LorenzW.J. (1992). ‘Computer systems and mechanical tools for stereotactically guided conformation therapy with linear accelerators,’ Int. J. Radiat. Oncol. Biol. Phys.24, 781–787.
471.
SchneiderU., and PedroniE. (1995). ‘Proton radiography as a tool for quality control in proton therapy,’ Med. Phys.22, 353–363.
472.
SchneiderU., PedroniE., and LomaxA. (1996). ‘The calibration of CT Hounsfield units for radiotherapy treatment planning,’ Phys. Med. Biol.41, 111–124.
473.
SchoemersC., FeldmeierE., NaumannJ., PanseR., PetersA., and HabererT. (2015). ‘The intensity feedback system at Heidelberg Ion-Beam Therapy Centre,’ Nucl. Instrum. Methods Phys. Res. A795, 92–99.
474.
ScholzM., and ElsässerT. (2007). ‘Biophysical models in ion beam radiotherapy,’ Adv. Space Res.40, 1381–1391.
475.
ScholzM., and KraftG. (1996). ‘Track structure and the calculation of biological effects of heavy charged particles,’ Adv. Space Res.18, 5–14.
476.
ScholzM., KellererA.M., Kraft-WeyratherW., and KraftG. (1997). ‘Computation of cell survival in heavy ion beams for therapy. The model and its approximation,’ Radiat. Environ. Biophys.36, 59–66.
477.
SchuemannJ., DowdellS., GrassbergerC., MinC.H., and PaganettiH. (2014). ‘Site-specific range uncertainties caused by dose calculation algorithms for proton therapy,’ Phys. Med. Biol.59, 4007–4031.
478.
SchulzR.J., VenkataramananN., and HuqM.S. (1990). ‘The thermal defect of A-150 plastic and graphite for low-energy protons,’ Phys. Med. Biol.35, 1563–1574.
479.
Schulz-ErtnerD., and TsujiiH. (2007). ‘Particle radiation therapy using proton and heavier ion beams,’ J. Clin. Oncol.25, 953–964.
480.
Schulz-ErtnerD., NikoghosyanA., JäkelO., HabererT., KraftG., ScholzM., WannenmacherM., and DebusJ. (2003a). ‘Feasibility and toxicity of combined photon and carbon ion radiotherapy for locally advanced adenoid cystic carcinomas,’ Int. J. Radiat. Oncol. Biol. Phys.56, 391–398.
481.
Schulz-ErtnerD., DidingerB., NikoghosyanA., JäkelO., ZunaI., WannenmacherM., and DebusJ. (2003b). ‘Optimization of radiation therapy for locally advanced adenoid cystic carcinomas with infiltration of the skull base using photon intensity-modulated radiation therapy (IMRT) and a carbon ion boost,’ Strahlenther. Onkol.179, 345–351.
482.
Schulz-ErtnerD., NikoghosyanA., ThilmannC., HabererT., JäkelO., KargerC., KraftG., WannenmacherM., and DebusJ. (2004). ‘Results of carbon ion radiotherapy in 152 patients,’ Int. J. Radiat. Oncol. Biol. Phys.58, 631–640.
483.
Schulz-ErtnerD., NikoghosyanA., DidingerB., MünterM., JäkelO., KargerC.P., and DebusJ. (2005). ‘Therapy strategies for locally advanced adenoid cystic carcinomas using modern radiation therapy techniques,’ Cancer104, 338–344.
484.
Schulz-ErtnerD., KargerC.P., FeuerhakeA., NikoghosyanA., CombsS.E., JäkelO., EdlerL., ScholzM., and DebusJ. (2007a). ‘Effectiveness of carbon ion radiotherapy in the treatment of skull-base chordomas,’ Int. J. Radiat. Oncol. Biol. Phys.68, 449–457.
485.
SchwaabJ., PrallM., SartiC., KaderkaR., BertC., KurzC., ParodiK., GuntherM., and JenneJ. (2014). ‘Ultrasound tracking for intra-fractional motion compensation in radiation therapy,’ Phys. Med.30, 578–582.
486.
SchwahoferA., BarE., KuchenbeckerS., GrossmannJ.G., KachelriessM., and SterzingF. (2015). ‘The application of metal artifact reduction (MAR) in CT scans for radiation oncology by monoenergetic extrapolation with a DECT scanner,’ Z. Med. Phys.25, 314–325.
487.
SchweikardA., ShiomiH., and AdlerJ. (2005). ‘Respiration tracking in radiosurgery without fiducials,’ Int. J. Med. Robot.1, 19–27.
488.
SecoJ., RobertsonD., TrofimovA., and PaganettiH. (2009). ‘Breathing interplay effects during proton beam scanning: simulation and statistical analysis,’ Phys. Med. Biol.54, N283–N294.
489.
SeilerP.G., BlattmannH., KirschS., MuenchR.K., and SchillingC. (2000). ‘A novel tracking technique for the continuous precise measurement of tumour positions in conformal radiotherapy,’ Phys. Med. Biol.45, N103–N110.
490.
ShimizuS., MiyamotoN., MatsuuraT., FujiiY., UmezawaM., UmegakiK., HiramotoK., and ShiratoH. (2014). ‘A proton beam therapy system dedicated to spot-scanning increases accuracy with moving tumors by real-time imaging and gating and reduces equipment size,’ PLoS One9, e94971.
491.
Shiomi-TsudaN., SakamotoN., OgawaH., TanakaM., SaithoM., and KitobaU. (1999). ‘Stopping powers of N2 and O2 for protons from 4.0 to 13.0 MeV,’ Nucl. Instrum. Methods Phys. Res. B149, 17–24.
492.
ShiratoH., HaradaT., HarabayashiT., HidaK., EndoH., KitamuraK., OnimaruR., YamazakiK., KurauchiN., ShimizuT., ShinoharaN., MatsushitaM., Dosaka-AkitaH., and MiyasakaK. (2003). ‘Feasibility of insertion/implantation of 2.0-mm-diameter gold internal fiducial markers for precise setup and real-time tumor tracking in radiotherapy,’ Int. J. Radiat. Oncol. Biol. Phys.56, 240–247.
493.
ShiratoH., OitaM., FujitaK., WatanabeY., and MiyasakaK. (2004). ‘Feasibility of synchronization of real-time tumor-tracking radiotherapy and intensity-modulated radiotherapy from viewpoint of excessive dose from fluoroscopy,’ Int. J. Radiat. Oncol. Biol. Phys.60, 335–341.
494.
ShiratoH., OnimaruR., IshikawaM., KanekoJ., TakeshimaT., MochizukiK., ShimizuS., and UmegakiK. (2012). ‘Real-time 4-D radiotherapy for lung cancer,’ Cancer Sci.103, 1–6.
495.
SihverL., TsaoC.H., SilberbergR., BarghoutyA.F., and KanaiT. (1996). ‘Calculations of depth-dose distributions, cross sections and momentum loss,’ Adv. Space Res.17, 105–108.
496.
SihverL., SchardtD., and KanaiT. (1998). ‘Depth-dose distributions of high-energy carbon, oxygen and neon beams in water,’ Jpn. J. Med. Phys.18, 1–21.
497.
SlaterJ.D., SlaterJ.M., and SchulteR.W. (1995). ‘Proton beam therapy at Loma Linda University Medical Center: Clinical experience of the first four years,’ Progress in Radio-oncology V (J Overgaard, ed.), 673–679.
498.
SlaterJ.D., YonemotoL.T., RossiC.J.Jr., Reyes-MolyneuxN.J., BushD.A., AntoineJ.E., LoredoL.N., SchulteR.W., TeichmanS.L., and SlaterJ.M. (1998). ‘Conformal proton therapy for prostate carcinoma,’ Int. J. Radiat. Oncol. Biol. Phys.42, 299–304.
499.
SlaterJ.M., ArchambeauJ.O., MillerD.W., NotarusM.I., PrestonW., and SlaterJ.D. (1992). ‘The Proton Treatment Center at Loma-Linda-University-Medical-Center – rationale for and description of its development,’ Int. J. Radiat. Oncol. Biol. Phys.22, 383–389.
500.
SonkeJ.J., and BelderbosJ. (2010). ‘Adaptive radiotherapy for lung cancer,’ Semin. Radiat. Oncol.20, 94–106.
501.
SonkeJ.J., LebesqueJ., and van HerkM. (2008). ‘Variability of four-dimensional computed tomography patient models,’ Int. J. Radiat. Oncol. Biol. Phys.70, 590–598.
502.
SpielbergerB., ScholzM., KramerM., and KraftG. (2001). ‘Experimental investigations of the response of films to heavy-ion irradiation,’ Phys. Med. Biol.46, 2889–2897.
503.
SpielbergerB., ScholzM., KramerM., and KraftG. (2002). ‘Calculation of the x-ray film response to heavy charged particle irradiation,’ Phys. Med. Biol.47, 4107–4120.
504.
SpielbergerB., KramerM., and KraftG. (2003). ‘Three-dimensional dose verification with x-ray films in conformal carbon ion therapy,’ Phys. Med. Biol.48, 497–505.
505.
SpoelstraF.O., SenanS., Le PechouxC., IshikuraS., CasasF., BallD., PriceA., De RuysscherD., and van Sornsen de KosteJ.R.Lung Adjuvant Radiotherapy Trial Investigators Group (2010). ‘Variations in target volume definition for postoperative radiotherapy in stage III non-small-cell lung cancer: Analysis of an international contouring study,’ Int. J. Radiat. Oncol. Biol. Phys.76, 1106–1113.
506.
SteinsträterO., GrunR., ScholzU., FriedrichT., DuranteM., and ScholzM. (2012). ‘Mapping of RBE-weighted doses between HIMAC- and LEM-based treatment planning systems for carbon ion therapy,’ Int. J. Radiat. Oncol. Biol. Phys.84, 854–860.
507.
SteitzJ., NaumannP., UlrichS., HaefnerM.F., SterzingF., OelfkeU., and BangertM. (2016). ‘Worst case optimization for interfractional motion mitigation in carbon ion therapy of pancreatic cancer,’ Radiat. Oncol.11, 134.
508.
StützerK., BertC., EnghardtW., HelmbrechtS., ParodiK., PriegnitzM., SaitoN., and FiedlerF. (2013). ‘Experimental verification of a 4D MLEM reconstruction algorithm used for in-beam PET measurements in particle therapy,’ Phys. Med. Biol.58, 5085–5111.
509.
SuitH.D., and ChuW. (2008). ‘History of charged particle radiotherapy,’ pp. 1–7 in Proton and Charged Particle Radiotherapy, DeLaney, T.F., and Kooy, H.M., Eds. (Lippincott Williams & Wilkins, Philadelphia, Pennsylvania).
510.
SuitH.D., GoiteinM., TepperJ., KoehlerA.M., SchmidtR.A., and SchneiderR. (1975). ‘Exploratory study of proton radiation-therapy using large field techniques and fractionated dose schedules,’ Cancer35, 1646–1657.
511.
SuzukiM., KaseY., YamaguchiH., KanaiT., and AndoK. (2000). ‘Relative biological effectiveness for cell-killing effect on various human cell lines irradiated with heavy-ion medical accelerator in CHIBA (HIMAC) carbon-ion beams,’ Int. J. Radiat. Oncol. Biol. Phys.48, 241–250.
512.
TangS., DevilleC., McDonoughJ., TochnerZ., WangK.K., VapiwalaN., and BothS. (2013). ‘Effect of intrafraction prostate motion on proton pencil beam scanning delivery: a quantitative assessment,’ Int. J. Radiat. Oncol. Biol. Phys.87, 375–382.
513.
TashimaH., YoshidaE., InadamaN., NishikidoF., NakajimaY., WakizakaH., ShinajiT., NittaM., KinouchiS., SugaM., HaneishiH., InaniwaT., and YamayaT. (2016). ‘Development of a small single-ring OpenPET prototype with a novel transformable architecture,’ Phys. Med. Biol.61, 1795–1809.
514.
TashiroM., IshiiT., KoyaJ., OkadaR., KurosawaY., AraiK., AbeS., OhashiY., ShimadaH., YusaK., KanaiT., YamadaS., KawamuraH., EbaraT., OhnoT., and NakanoT. (2013). ‘Technical approach to individualized respiratory-gated carbon-ion therapy for mobile organs,’ Radiol. Phys. Technol.6, 356–366.
515.
TelsemeyerJ., AckermannB., EckerS., JäkelO., and MartišíkováM. (2014). ‘Experimental verification of ion range calculation in a treatment planning system using a flat-panel detector,’ Phys. Med. Biol.59, 3737.
516.
ThiekeC., MalschU., SchlegelW., DebusJ., HuberP., BendlR., and ThilmannC. (2006). ‘Kilovoltage CT using a linac-CT scanner combination,’ Br. J. Radiol.79, S79–S86.
517.
TobiasC.A. (1973). ‘Pretherapeutic investigations with accelerated heavy ions,’ Radiology108, 145–158.
518.
TobiasC., and SegreE. (1946). ‘High energy carbon nuclei,’ Phys. Rev.70, 89.
519.
TobiasC., and ToddP. (1967). ‘Radiobiology and radiotherapy,’ Natl. Cancer Inst. Monogr.24, 1–21.
520.
TobiasC.A., AngerH.O., and LawrenceJ.H. (1952). ‘Radiological use of high energy deuterons and alpha particles,’ Am. J. Roentgenol.67, 1–27.
521.
TobiasC., LawrenceJ., BornJ., McCombsR., RobertsJ., AngerH., Low-BeerB., and HugginsC. (1958). ‘Pituitary irradiation with high-energy proton beams a preliminary report,’ Cancer Res.18, 121–134.
522.
TobiasC.A., LymanJ.T., ChatterjeeA., HowardJ., MaccabeeH.D., RajuM.R., SmithA.R., SperindeJ.M., and WelchG.P. (1971). ‘Radiological physics characteristics of the extracted heavy ion beams of the bevatron,’ Science174, 1131–1134.
523.
ToddP., SchroyC.B., VosburghK.G., and SchimmerlingW. (1971). ‘Spatial distribution of biological effect n a 3.9-Gev nitrogen ion beam,’ Science174, 1127–1128.
524.
TorikoshiM., MinoharaS., KanematsuN., KomoriM., KanazawaM., NodaK., MiyaharaN., ItohH., EndoM., and KanaiT. (2007). ‘Irradiation system for HIMAC,’ J. Radiat. Res.48, A15–A25.
525.
TranL.T., ChartierL., BolstD., ProkopovichD.A., GuatelliS., NancarrowM., ReinhardM.I., PetaseccaM., LerchM.L., and PereverlayloV.L. (2015). ‘3D silicon microdosimetry and RBE study using 12C ion of different energies,’ IEEE Trans. Nucl. Sci.62, 3027–3033.
526.
TrbojevicD., ParkerB., KeilE., and SesslerA.M. (2007). ‘Carbon/proton therapy: a novel gantry design,’ Phys. Rev. Spec. Top-Ac10, 053503.
527.
TsujiH., YanagiT., IshikawaH., KamadaT., MizoeJ.E., KanaiT., MoritaS., and TsujiiH.Working Group for Genitourinary Tumors (2005). ‘Hypofractionated radiotherapy with carbon ion beams for prostate cancer,’ Int. J. Radiat. Oncol. Biol. Phys.63, 1153–1160.
528.
TsujiH., IshikawaH., YanagiT., HirasawaN., KamadaT., MizoeJ.-E., KanaiT., TsujiiH., and OhnishiY. (2007). ‘Carbon-ion radiotherapy for locally advanced or unfavorably located choroidal melanoma: a phase I/II dose-escalation study,’ Int. J. Radiat. Oncol. Biol. Phys.67, 857–862.
529.
TsujiiH. (2006). ‘Progress and perspectives of carbon ion radiotherapy at NIRS,’
530.
TsujiiH., and KamadaT. (2012). ‘A review of update clinical results of carbon ion radiotherapy,’ Jpn. J. Clin. Oncol.42, 670–685.
531.
TsujiiH., MizoeJ., KamadaT., BabaM., KatoS., KatoH., TsujiH., YamadaS., YasudaS., OhnoT., YanagiT., HasegawaA., SugawaraT., EzawaH., KandatsuS., YoshikawaK., KishimotoR., and MiyamotoT. (2004). ‘Overview of clinical experiences on carbon ion radiotherapy at NIRS,’ Radiother. Oncol.73, 41.
532.
TsujiiH., MizoeJ., KamadaT., BabaM., TsujiH., KatoH., KatoS., YamadaS., YasudaS., OhnoT., YanagiT., ImaiR., KageK., KatoH., HaraR., HasegawaA., NakajimaM., SuganeN., TamakiN., TakagiR., KandatsuS., YoshikawaK., KishimotoR., and MiyamotoT. (2007). ‘Clinical results of carbon ion radiotherapy at NIRS,’ J. Radiat. Res.48, A1–A13.
533.
TsunemotoH., AraiT., MoritaS., IshikawaT., AokiY., TakadaN., and KamataS. (1982). ‘Japanese experience with clinical trials of fast neutrons,’ Int. J. Radiat. Oncol. Biol. Phys.8, 2169–2172.
534.
UematsuM., FukuiT., ShiodaA., TokumitsuH., TakaiK., KojimaT., AsaiY., and KusanoS. (1996). ‘A dual computed tomography linear accelerator unit for stereotactic radiation therapy: a new approach without cranially fixated stereotactic frames,’ Int. J. Radiat. Oncol. Biol. Phys.35, 587–592.
535.
UhlV., CastroJ.R., KnopfK., PhillipsT.L., CollierJ.M., PettiP.L., and DaftariI. (1992). ‘Preliminary results in heavy charged particle irradiation of bone sarcoma,’ Int. J. Radiat. Oncol. Biol. Phys.24, 755–759.
536.
UnkelbachJ., BortfeldT., MartinB.C., and SoukupM. (2009). ‘Reducing the sensitivity of IMPT treatment plans to setup errors and range uncertainties via probabilistic treatment planning,’ Med. Phys.36, 149–163.
537.
UrakabeE., KanaiT., KanazawaM., KitagawaA., NodaK., TomitaniT., SudaM., IsekiY., HanawaK., and SatoK. (2001). ‘Spot scanning using radioactive 11C beams for heavy-ion radiotherapy,’ Jpn. J. Appl. Phys.40, 2540.
538.
UrieM., GoiteinM., and WagnerM. (1984). ‘Compensating for heterogeneities in proton radiation therapy,’ Phys. Med. Biol.29, 553–566.
539.
UzawaA., AndoK., FurusawaY., KagiyaG., FujiH., HataM., SakaeT., TerunumaT., ScholzM., RitterS., and PeschkeP. (2007). ‘Biological intercomparison using gut crypt survivals for proton and carbon-ion beams,’ J. Radiat. Res.48, A75–A80.
540.
UzawaA., AndoK., KoikeS., FurusawaY., MatsumotoY., TakaiN., HirayamaR., WatanabeM., ScholzM., ElsässerT., and PeschkeP. (2009). ‘Comparison of biological effectiveness of carbon-ion beams in Japan and Germany,’ Int. J. Radiat. Oncol. Biol. Phys.73, 1545–1551.
541.
VanderstraetenB., DuthoyW., De GersemW., De NeveW., and ThierensH. (2006). ‘[18F]fluoro-deoxy-glucose positron emission tomography ([18F]FDG-PET) voxel intensity-based intensity-modulated radiation therapy (IMRT) for head and neck cancer,’ Radiother. Oncol.79, 249–258.
542.
van HerkM. (2004). ‘Errors and margins in radiotherapy,’ Semin. Radiat. Oncol.14, 52–64.
543.
VeigaC., JanssensG., TengC.L., BaudierT., HotoiuL., McClellandJ.R., RoyleG., LinL., YinL., MetzJ., SolbergT.D., TochnerZ., SimoneC.B.II, McDonoughJ., and TeoB.K. (2016). ‘First clinical investigation of cone beam computed tomography and deformable registration for adaptive proton therapy for lung cancer,’ Int. J. Radiat. Oncol. Biol. Phys.95, 549–559.
544.
VynckierS., BonnettD.E., and JonesD.T. (1991). ‘Code of practice for clinical proton dosimetry,’ Radiother. Oncol.20, 53–63.
545.
VynckierS., BonnettD.E., and JonesD.T. (1994). ‘Supplement to the code of practice for clinical proton dosimetry. ECHED (European Clinical Heavy Particle Dosimetry Group),’ Radiother. Oncol.32, 174–179.
546.
WachterS., GerstnerN., DornerD., GoldnerG., ColottoA., WambersieA., and PotterR. (2002). ‘The influence of a rectal balloon tube as internal immobilization device on variations of volumes and dose-volume histograms during treatment course of conformal radiotherapy for prostate cancer,’ Int. J. Radiat. Oncol. Biol. Phys.52, 91–100.
547.
WambersieA., DelucaP.M., AndreoP., and HendryJ.H. (2004). ‘“Light” or “heavy” ions: a debate of terminology?,’ Radiother. Oncol.73, iiii.
548.
WangD., BoschW., KirschD.G., Al LoziR., El NaqaI., RobergeD., FinkelsteinS.E., PetersenI., HaddockM., ChenY.L., SaitoN.G., HitchcockY.J., WolfsonA.H., and DeLaneyT.F. (2011). ‘Variation in the gross tumor volume and clinical target volume for preoperative radiotherapy of primary large high-grade soft tissue sarcoma of the extremity among RTOG sarcoma radiation oncologists,’ Int. J. Radiat. Oncol. Biol. Phys.81, e775–e780.
549.
WeberU., and KraftG. (1999). ‘Design and construction of a ripple filter for a smoothed depth dose distribution in conformal particle therapy,’ Phys. Med. Biol.44, 2765–2775.
550.
WeberU., and KraftG. (2009). ‘Comparison of carbon ions versus protons,’ Cancer J.15, 325–332.
551.
WeissE., and HessC.F. (2003). ‘The impact of gross tumor volume (GTV) and clinical target volume (CTV) definition on the total accuracy in radiotherapy theoretical aspects and practical experiences,’ Strahlenther. Onkol.179, 21–30.
552.
WeltensC., MentenJ., FeronM., BellonE., DemaerelP., MaesF., Van den BogaertW., and van der SchuerenE. (2001). ‘Interobserver variations in gross tumor volume delineation of brain tumors on computed tomography and impact of magnetic resonance imaging,’ Radiother. Oncol.60, 49–59.
553.
WenzlT., and WilkensJ.J. (2011). ‘Modelling of the oxygen enhancement ratio for ion beam radiation therapy,’ Phys. Med. Biol.56, 3251–3268.
554.
WertzH., and JäkelO. (2004). ‘Influence of iodine contrast agent on the range of ion beams for radiotherapy,’ Med. Phys.31, 767–773.
555.
WhiteM.G., IsailaM., PrelecK., and AllenH.L. (1971). ‘Acceleration of nitrogen ions to 7.4 GeV in the Princeton particle accelerator,’ Science174, 1121–1123.
556.
WilloughbyT.R., ForbesA.R., BuchholzD., LangenK.M., WagnerT.H., ZeidanO.A., KupelianP.A., and MeeksS.L. (2006a). ‘Evaluation of an infrared camera and x-ray system using implanted fiducials in patients with lung tumors for gated radiation therapy,’ Int. J. Radiat. Oncol. Biol. Phys.66, 568–575.
557.
WilloughbyT.R., KupelianP.A., PouliotJ., ShinoharaK., AubinM., RoachM., SkrumedaL.L., BalterJ.M., LitzenbergD.W., HadleyS.W., WeiJ.T., and SandlerH.M. (2006b). ‘Target localization and real-time tracking using the calypso 4D localization system in patients with localized prostate cancer,’ Int. J. Radiat. Oncol. Biol. Phys.65, 528–534.
558.
WilsonR.R. (1946). ‘Radiological use of fast protons,’ Radiology47, 487–491.
559.
WilsonR. (1997). ‘Foreword to the Second International Symposium on Hadrontherapy,’ in Advances in Hadron Therapy: Proceedings of the Second International Symposium on Hadrontherapy, No. 1144, Amaldi, U., Larsson, B., and Lemoigne, Y., Eds. (Elsevier Science, New York).
560.
WithersH.R., TaylorJ.M., and MaciejewskiB. (1988). ‘Treatment volume and tissue tolerance,’ Int. J. Radiat. Oncol. Biol. Phys.14, 751–759.
561.
WohlfahrtP., MöhlerC., RichterC., GreilichS. (2018). ‘Evaluation of stopping-power prediction by dual- and single-energy computed tomography in an anthropomorphic ground-truth phantom,’ Int. J. Radiat. Oncol. Biol. Phys.100, 244–253.
562.
WolfelschneiderJ., FriedrichT., LuchtenborgR., ZinkK., ScholzM., DongL., DuranteM., and BertC. (2016). ‘Impact of fractionation and number of fields on dose homogeneity for intra-fractionally moving lung tumors using scanned carbon ion treatment,’ Radiother. Oncol.118, 498–503.
563.
WongJ.W., SharpeM.B., JaffrayD.A., KiniV.R., RobertsonJ.M., StrombergJ.S., and MartinezA.A. (1999). ‘The use of active breathing control (ABC) to reduce margin for breathing motion,’ Int. J. Radiat. Oncol. Biol. Phys.44, 911–919.
564.
WoodruffK.H., CastroJ.R., QuiveyJ.M., SaundersW.M., ChenG.T., LymanJ.T., PitluckS., TobiasC.A., WaltonR.E., and PetersT.C. (1984). ‘Postmortem examination of 22 pancreatic carcinoma patients treated with helium ion irradiation,’ Cancer53, 420–425.
565.
YajimaK., KanaiT., KusanoY., and ShimojyuT. (2009). ‘Development of a multi-layer ionization chamber for heavy-ion radiotherapy,’ Phys. Med. Biol.54, N107–N114.
566.
YamadaT., MiyamotoN., MatsuuraT., TakaoS., FujiiY., MatsuzakiY., KoyanoH., UmezawaM., NihongiH., ShimizuS., ShiratoH., and UmegakiK. (2016). ‘Optimization and evaluation of multiple gating beam delivery in a synchrotron-based proton beam scanning system using a real-time imaging technique,’ Phys. Med.32, 932–937.
YanagiT., KamadaT., TsujiH., ImaiR., SerizawaI., and TsujiiH. (2010). ‘Dose-volume histogram and dose-surface histogram analysis for skin reactions to carbon ion radiotherapy for bone and soft tissue sarcoma,’ Radiother. Oncol.95, 60–65.
569.
YonaiS., MatsufujiN., KanaiT., MatsuiY., MatsushitaK., YamashitaH., NumanoM., SakaeT., TerunumaT., NishioT., KohnoR., and AkagiT. (2008a). ‘Measurement of neutron ambient dose equivalent in passive carbon-ion and proton radiotherapies,’ Med. Phys.35, 4782–4792.
570.
YonaiS., KanematsuN., KomoriM., KanaiT., TakeiY., TakahashiO., IsobeY., TashiroM., KoikegamiH., and TomitaH. (2008b). ‘Evaluation of beam wobbling methods for heavy-ion radiotherapy,’ Med. Phys.35, 927–938.
571.
YonaiS., KaseY., MatsufujiN., KanaiT., NishioT., NambaM., and YamashitaW. (2010). ‘Measurement of absorbed dose, quality factor, and dose equivalent in water phantom outside of the irradiation field in passive carbon-ion and proton radiotherapies,’ Med. Phys.37, 4046–4055.
572.
YonaiS., MatsufujiN., and NambaM. (2012). ‘Calculation of out-of-field dose distribution in carbon-ion radiotherapy by Monte Carlo simulation,’ Med. Phys.39, 5028–5039.
573.
YonaiS., FurukawaT., and InaniwaT. (2014). ‘Measurement of neutron ambient dose equivalent in carbon-ion radiotherapy with an active scanned delivery system,’ Radiat. Prot. Dosimetry161, 433–436.
574.
YonekuraY., TsujiiH., HopewellJ.W., LopezP.O., CossetJ.M., PaganettiH., MonteliusA., SchardtD., JonesB., and NakamuraT.International Commission on Radiological Protection (2014). ‘ICRP Publication 127: Radiological protection in ion beam radiotherapy,’ Ann. ICRP43, 5–113.
575.
YorkeE.D. (2003). ‘Biological indices for evaluation and optimization of IMRT,’ pp. 77–114 in Teletherapy: Present and Future, Palta, J., and Mackie, T.R., Eds. (American Association of Physicists in Medicine, College Park, Maryland).
ThomasZacharias, WolfgangDörr, WolfgangEnghardt, ThomasHaberer, MichaelKrämer, RainerKumpf, HolgerRöthig, MichaelScholz, UliWeber, GerhardKraft & ThomasHerrmann (1997) Acute Response of Pig Skin to Irradiation with 12C-ions or 200 kV X-rays, Acta Oncologica, 36:6, 637–642, DOI: 10.3109/02841869709001328
578.
ZaiderM., and RossiH.H. (1980). ‘The synergistic effects of different radiations,’ Radiat. Res.83, 732–739.
579.
ZaiderM., and RossiH.H. (1988). ‘On the application of microdosimetry to radiobiology,’ Radiat. Res.113, 15–24.
580.
ZaiderM., DicelloJ., BrennerD., TakaiM., RajuM., and HowardJ. (1981). ‘Microdosimetry of range-modulated bearns of heavy ions: I. Determination of the yield of projectile fragments from microdosimetric spectra for neon-10 beams,’ Radiat. Res.87, 511–520.
581.
ZechnerA., StockM., KellnerD., ZieglerI., KeuschniggP., HuberP., MayerU., SedlmayerF., DeutschmannH., and SteiningerP. (2016). ‘Development and first use of a novel cylindrical ball bearing phantom for 9-DOF geometric calibrations of flat panel imaging devices used in image-guided ion beam therapy,’ Phys. Med. Biol.61, N592–N605.
582.
ZhangH., LiS., WangX.H., LiQ., WeiS.H., GaoL.Y., ZhaoW.P., HuZ.G., MaoR.S., XuH.S., ZhangQ.N., YueY.J., TianZ.Z., RanJ.T., XiaoG.Q., and ZhanW.L. (2012). ‘Results of carbon ion radiotherapy for skin carcinomas in 45 patients,’ Br. J. Dermatol.166, 1100–1106.
583.
ZhuX.R., PoenischF., SongX., JohnsonJ.L., CiangaruG., TaylorM.B., LiiM., MartinC., ArjomandyB., LeeA.K., ChoiS., NguyenQ.N., GillinM.T., and SahooN. (2011). ‘Patient-specific quality assurance for prostate cancer patients receiving spot scanning proton therapy using single-field uniform dose,’ Int. J. Radiat. Oncol. Biol. Phys.81, 552–559.
584.
ZieglerJ.F., BiersackJ.P., and ZieglerM.D. (2008). SRIM - The Stopping Power and Range of Ions in Matter [online], http://www.srim.org/ (July 18 2018, date last accessed) (SRIM Co., Chester, Maryland).
585.
ZinkS.R., LymanJ.T., CastroJ.R., ChenG.T., CollierJ.M., and SaundersW.M. (1988). ‘Treatment planning study for carcinoma of the esophagus: helium ions versus photons,’ Int. J. Radiat. Oncol. Biol. Phys.14, 993–1000.